{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 535790, "items": [{"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T13:58:28Z", "timestamp": 1574690308377}, "reference-count": 34, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Retina"], "published-print": {"date-parts": [[2015, 6]]}, "DOI": "10.1097/iae.0000000000000606", "type": "journal-article", "created": {"date-parts": [[2015, 5, 1]], "date-time": "2015-05-01T20:18:31Z", "timestamp": 1430511511000}, "page": "1173-1183", "source": "Crossref", "is-referenced-by-count": 21, "title": ["PHASE II, RANDOMIZED, PLACEBO-CONTROLLED, 90-DAY STUDY OF EMIXUSTAT HYDROCHLORIDE IN GEOGRAPHIC ATROPHY ASSOCIATED WITH DRY AGE-RELATED MACULAR DEGENERATION"], "prefix": "10.1097", "volume": "35", "author": [{"given": "Pravin U.", "family": "Dugel", "sequence": "first", "affiliation": []}, {"given": "Roger L.", "family": "Novack", "sequence": "additional", "affiliation": []}, {"given": "Karl G.", "family": "Csaky", "sequence": "additional", "affiliation": []}, {"given": "Preston P.", "family": "Richmond", "sequence": "additional", "affiliation": []}, {"given": "David G.", "family": "Birch", "sequence": "additional", "affiliation": []}, {"given": "Ryo", "family": "Kubota", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Retina"], "language": "en", "deposited": {"date-parts": [[2018, 2, 9]], "date-time": "2018-02-09T14:09:13Z", "timestamp": 1518185353000}, "score": 97.12712, "subtitle": [""], "issued": {"date-parts": [[2015, 6]]}, "references-count": 34, "journal-issue": {"issue": "6"}, "URL": "http://dx.doi.org/10.1097/iae.0000000000000606", "ISSN": ["0275-004X"], "issn-type": [{"value": "0275-004X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T12:25:25Z", "timestamp": 1575289525248}, "reference-count": 36, "publisher": "Elsevier BV", "issue": "10", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2018, 10, 1]], "date-time": "2018-10-01T00:00:00Z", "timestamp": 1538352000000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/", "start": {"date-parts": [[2018, 4, 20]], "date-time": "2018-04-20T00:00:00Z", "timestamp": 1524182400000}, "delay-in-days": 0, "content-version": "vor"}], "content-domain": {"domain": ["clinicalkey.jp", "aaojournal.org", "clinicalkey.com", "clinicalkey.es", "clinicalkey.fr", "clinicalkey.com.au", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Ophthalmology"], "published-print": {"date-parts": [[2018, 10]]}, "DOI": "10.1016/j.ophtha.2018.03.059", "type": "journal-article", "created": {"date-parts": [[2018, 4, 30]], "date-time": "2018-04-30T09:15:26Z", "timestamp": 1525079726000}, "page": "1556-1567", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 13, "title": ["Emixustat Hydrochloride for Geographic Atrophy Secondary to Age-Related Macular Degeneration"], "prefix": "10.1016", "volume": "125", "author": [{"given": "Philip J.", "family": "Rosenfeld", "sequence": "first", "affiliation": []}, {"given": "Pravin U.", "family": "Dugel", "sequence": "additional", "affiliation": []}, {"given": "Frank G.", "family": "Holz", "sequence": "additional", "affiliation": []}, {"ORCID": "http://orcid.org/0000-0003-4625-3145", "authenticated-orcid": false, "given": "Jeffrey S.", "family": "Heier", "sequence": "additional", "affiliation": []}, {"given": "Joel A.", "family": "Pearlman", "sequence": "additional", "affiliation": []}, {"given": "Roger L.", "family": "Novack", "sequence": "additional", "affiliation": []}, {"given": "Karl G.", "family": "Csaky", "sequence": "additional", "affiliation": []}, {"given": "John M.", "family": "Koester", "sequence": "additional", "affiliation": []}, {"given": "Jeffrey K.", "family": "Gregory", "sequence": "additional", "affiliation": []}, {"given": "Ryo", "family": "Kubota", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Ophthalmology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0161642017338782?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0161642017338782?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 20]], "date-time": "2018-11-20T01:03:33Z", "timestamp": 1542675813000}, "score": 52.322838, "issued": {"date-parts": [[2018, 10]]}, "references-count": 36, "journal-issue": {"published-print": {"date-parts": [[2018, 10]]}, "issue": "10"}, "alternative-id": ["S0161642017338782"], "URL": "http://dx.doi.org/10.1016/j.ophtha.2018.03.059", "ISSN": ["0161-6420"], "issn-type": [{"value": "0161-6420", "type": "print"}], "subject": ["Ophthalmology"], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Emixustat Hydrochloride for Geographic Atrophy Secondary to Age-Related Macular Degeneration", "name": "articletitle", "label": "Article Title"}, {"value": "Ophthalmology", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.ophtha.2018.03.059", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "\u00a9 2018 by the American Academy of OphthalmologyThis is an open access article under the CC BY-NC-ND license (<inter-ref xlink: href=http://creativecommons.org/licenses/by-nc-nd/4.0/>http://creativecommons.org/licenses/by-nc-nd/4.0/</inter-ref>).", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T12:18:32Z", "timestamp": 1575202712553}, "reference-count": 16, "publisher": "CRC Press", "isbn-type": [{"value": "9781841849492", "type": "print"}, {"value": "9781841849508", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2012, 11, 15]]}, "DOI": "10.1201/b14548-22", "type": "book-chapter", "created": {"date-parts": [[2013, 3, 27]], "date-time": "2013-03-27T14:57:51Z", "timestamp": 1364396271000}, "page": "255-259", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Radiation therapy for age-related macular degeneration"], "prefix": "10.1201", "author": [{"given": "Madhavi", "family": "Kurli", "sequence": "first", "affiliation": []}, {"given": "Paul", "family": "Finger", "sequence": "additional", "affiliation": []}, {"given": "Pravin", "family": "Dugel", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2013, 3, 27]]}, "reference": [{"key": "p_3", "DOI": "10.1001/archopht.1984.01040031330019", "doi-asserted-by": "publisher"}, {"key": "p_6", "volume-title": "as well as low numbers of required anti- Med 2006"}, {"key": "p_13", "volume": "36", "first-page": "873", "year": "1996", "journal-title": "Phys"}, {"key": "p_14", "DOI": "10.1136/bjo.79.6.562", "doi-asserted-by": "publisher"}, {"key": "p_15", "DOI": "10.1016/0360-3016(94)90347-6", "doi-asserted-by": "publisher"}, {"key": "p_16", "author": "Willett CG", "volume": "10", "first-page": "1987", "year": "2004", "journal-title": "Nat Med"}, {"key": "p_17", "author": "Senan S", "year": "1995", "volume-title": "Design of clinical trials of radiation ation on the eye and ocular adnexa. Int J Radiat Oncol combined with antiangiogenic therapy. Oncologist 2007"}, {"key": "p_18", "DOI": "10.1136/bjo.77.5.265", "doi-asserted-by": "publisher"}, {"key": "p_19", "DOI": "10.1007/BF00193119", "doi-asserted-by": "publisher"}, {"key": "p_20", "author": "Berta A", "volume-title": "Landers MB 3rd, Wolbarsht ML. Increased retinal neovascularization using ruthenium applicators. retinal oxygen supply following pan-retinal photocoagu-Szemeset (Hung J Ophthalmol) 1995"}, {"key": "p_21", "author": "Finger PT", "year": "1996", "volume-title": "Radiation therapy thalmol Soc 1981"}, {"key": "p_22", "DOI": "10.1136/bjo.87.12.1497", "doi-asserted-by": "publisher"}, {"key": "p_23", "author": "Berson AM", "volume": "41", "first-page": "31", "year": "1996", "journal-title": "Int J Radiat Oncol Biol Phys Oncol"}, {"key": "p_24", "author": "Freire J", "volume": "56", "first-page": "941", "year": "1996", "journal-title": "Cancer Res"}, {"key": "p_25", "author": "Yonemoto LT", "year": "1996", "volume-title": "Phase I/II ocular, epiretinal radiation therapy for the treatment of study of proton beam irradiation for the treatment of subfoveal CNV secondary to AMD. Retina 2009"}, {"key": "p_26", "author": "Jaakkola A", "volume": "35", "first-page": "1998", "year": "2008", "journal-title": "Med Phys"}], "container-title": ["Age-Related Macular Degeneration, Third Edition"], "link": [{"URL": "http://www.crcnetbase.com/doi/pdf/10.1201/b14548-22", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 9, 10]], "date-time": "2016-09-10T05:52:15Z", "timestamp": 1473486735000}, "score": 51.615757, "issued": {"date-parts": [[2012, 11, 15]]}, "ISBN": ["9781841849492", "9781841849508"], "references-count": 16, "alternative-id": ["10.1201/b14548-22", "10.1201/b14548"], "URL": "http://dx.doi.org/10.1201/b14548-22", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T05:12:23Z", "timestamp": 1574745143698}, "reference-count": 0, "publisher": "Informa UK Limited", "license": [{"URL": "http://creativecommons.org/licenses/by-nc/3.0/", "start": {"date-parts": [[2015, 11, 1]], "date-time": "2015-11-01T00:00:00Z", "timestamp": 1446336000000}, "delay-in-days": 0, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["OPTH"], "DOI": "10.2147/opth.s92359", "type": "journal-article", "created": {"date-parts": [[2015, 11, 23]], "date-time": "2015-11-23T00:41:14Z", "timestamp": 1448239274000}, "page": "2159", "source": "Crossref", "is-referenced-by-count": 30, "title": ["Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospects"], "prefix": "10.2147", "author": [{"given": "Ronald P", "family": "Danis", "sequence": "first", "affiliation": []}, {"given": "Jeremy", "family": "Lavine", "sequence": "additional", "affiliation": []}, {"given": "Amitha", "family": "Domalpally", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2015, 11]]}, "container-title": ["Clinical Ophthalmology"], "language": "en", "link": [{"URL": "https://www.dovepress.com/getfile.php?fileID=28084", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 10, 30]], "date-time": "2016-10-30T22:22:52Z", "timestamp": 1477866172000}, "score": 47.8538, "issued": {"date-parts": [[2015, 11]]}, "references-count": 0, "URL": "http://dx.doi.org/10.2147/opth.s92359", "ISSN": ["1177-5483"], "issn-type": [{"value": "1177-5483", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T09:02:33Z", "timestamp": 1574499753614}, "publisher-location": "Berlin, Heidelberg", "reference-count": 38, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783642221064", "type": "print"}, {"value": "9783642221071", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2013]]}, "DOI": "10.1007/978-3-642-22107-1_17", "type": "book-chapter", "created": {"date-parts": [[2012, 8, 31]], "date-time": "2012-08-31T08:47:56Z", "timestamp": 1346402876000}, "page": "263-274", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Treatment Approaches for Dry AMD"], "prefix": "10.1007", "author": [{"given": "Z.", "family": "Yehoshua", "sequence": "first", "affiliation": []}, {"given": "P. J.", "family": "Rosenfeld", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2012, 4, 20]]}, "reference": [{"issue": "6", "key": "17_CR1", "doi-asserted-by": "crossref", "first-page": "933", "DOI": "10.1016/S0161-6420(92)31871-8", "volume": "99", "author": "R Klein", "year": "1992", "unstructured": "Klein R, Klein BE, Linton KL (1992) Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthal\u00admology 99(6):933\u2013943", "journal-title": "Ophthalmology"}, {"issue": "4", "key": "17_CR2", "doi-asserted-by": "publisher", "first-page": "564", "DOI": "10.1001/archopht.122.4.564", "volume": "122", "author": "DS Friedman", "year": "2004", "unstructured": "Friedman DS, O\u2019Colmain BJ, Munoz B et al (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122(4):564\u2013572", "journal-title": "Arch Ophthalmol"}, {"issue": "11", "key": "17_CR3", "doi-asserted-by": "publisher", "first-page": "1570", "DOI": "10.1001/archopht.123.11.1570", "volume": "123", "author": "FL Ferris", "year": "2005", "unstructured": "Ferris FL, Davis MD, Clemons TE et al (2005) A simplified severity scale for age-related macular degeneration: AREDS report no. 18. Arch Ophthalmol 123(11):1570\u20131574", "journal-title": "Arch Ophthalmol"}, {"issue": "10", "key": "17_CR4", "doi-asserted-by": "publisher", "first-page": "1417", "DOI": "10.1001/archopht.119.10.1417", "volume": "119", "author": "Age-Related Eye Disease Study Research Group", "year": "2001", "unstructured": "Age-Related Eye Disease Study Research Group (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119(10):1417\u20131436", "journal-title": "Arch Ophthalmol"}, {"issue": "6", "key": "17_CR5", "doi-asserted-by": "publisher", "first-page": "751", "DOI": "10.1038/eye.2008.100", "volume": "22", "author": "J Evans", "year": "2008", "unstructured": "Evans J (2008) Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review and meta-analysis. Eye (Lond) 22(6):751\u2013760", "journal-title": "Eye (Lond)"}, {"issue": "9", "key": "17_CR6", "doi-asserted-by": "publisher", "first-page": "935", "DOI": "10.1038/sj.eye.6701978", "volume": "19", "author": "J Thornton", "year": "2005", "unstructured": "Thornton J, Edwards R, Mitchell P et al (2005) Smoking and age-related macular degeneration: a review of association. Eye (Lond) 19(9):935\u2013944", "journal-title": "Eye (Lond)"}, {"issue": "12", "key": "17_CR7", "doi-asserted-by": "publisher", "first-page": "1728", "DOI": "10.1001/archopht.121.12.1728", "volume": "121", "author": "JM Seddon", "year": "2003", "unstructured": "Seddon JM, Cote J, Rosner B (2003) Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch Ophthalmol 121(12):1728\u20131737", "journal-title": "Arch Ophthalmol"}, {"issue": "1", "key": "17_CR8", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/j.preteyeres.2008.10.001", "volume": "28", "author": "X Ding", "year": "2009", "unstructured": "Ding X, Patel M, Chan CC (2009) Molecular pathology of age-related macular degeneration. Prog Retin Eye Res 28(1):1\u201318", "journal-title": "Prog Retin Eye Res"}, {"issue": "5", "key": "17_CR9", "doi-asserted-by": "publisher", "first-page": "856", "DOI": "10.1016/j.exer.2008.01.016", "volume": "86", "author": "S Kaidzu", "year": "2008", "unstructured": "Kaidzu S, Tanito M, Ohira A et al (2008) Immunohistochemical analysis of aldehyde-modified proteins in drusen in cynomolgus monkeys (Macaca fascicularis). Exp Eye Res 86(5):856\u2013859", "journal-title": "Exp Eye Res"}, {"issue": "3", "key": "17_CR10", "first-page": "CD006537", "volume": "8", "author": "MB Parodi", "year": "2009", "unstructured": "Parodi MB, Virgili G, Evans JR (2009) Laser treatment of drusen to prevent progression to advanced age-related macular degeneration. Cochrane Database Syst Rev 2009 Jul 8;(3):CD006537", "journal-title": "Cochrane Database Syst Rev 2009 Jul"}, {"issue": "2", "key": "17_CR11", "doi-asserted-by": "publisher", "first-page": "479", "DOI": "10.1167/iovs.07-1132", "volume": "49", "author": "KG Csaky", "year": "2008", "unstructured": "Csaky KG, Richman EA, Ferris FL 3rd (2008) Report from the NEI/FDA ophthalmic clinical trial design and endpoints symposium. Invest Ophthalmol Vis Sci 49(2):479\u2013489", "journal-title": "Invest Ophthalmol Vis Sci"}, {"key": "17_CR12", "first-page": "E", "volume": "51", "author": "PG Ralston", "year": "2010", "unstructured": "Ralston PG Jr, Sloan D, Waters-Honcu D et al (2010) A Pilot, open-label study of the safety of MC-1101 in both normal volunteers and patients with early nonexudative age-related macular degeneration. Invest Ophthalmol Vis Sci 51:E-Abstract 913", "journal-title": "Invest Ophthalmol Vis Sci"}, {"issue": "10", "key": "17_CR13", "first-page": "3292", "volume": "43", "author": "W Tao", "year": "2002", "unstructured": "Tao W, Wen R, Goddard MB et al (2002) Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa. Invest Ophthalmol Vis Sci 43(10):3292\u20133298", "journal-title": "Invest Ophthalmol Vis Sci"}, {"issue": "8", "key": "17_CR14", "doi-asserted-by": "publisher", "first-page": "3642", "DOI": "10.1167/iovs.02-0763", "volume": "44", "author": "WA Beltran", "year": "2003", "unstructured": "Beltran WA, Zhang Q, Kijas JW et al (2003) Cloning, mapping, and retinal expression of the canine ciliary neurotrophic factor receptor alpha (CNTFRalpha). Invest Ophthalmol Vis Sci 44(8):3642\u20133649", "journal-title": "Invest Ophthalmol Vis Sci"}, {"issue": "5", "key": "17_CR15", "first-page": "506", "volume": "10", "author": "DF Emerich", "year": "2008", "unstructured": "Emerich DF, Thanos CG (2008) NT-501: an ophthalmic implant of polymer-encapsulated ciliary neurotrophic factor-producing cells. Curr Opin Mol Ther 10(5):506\u2013515", "journal-title": "Curr Opin Mol Ther"}, {"key": "17_CR16", "first-page": "E", "volume": "50", "author": "GA Williams", "year": "2009", "unstructured": "Williams GA, Tao W (2009) A phase II study of encapsulated CNTF secreting cell implant (NT-501) in patients with visual acuity impairment associated with atrophic macular degeneration. Invest Ophthalmol Vis Sci 50:E-Abstract 5003", "journal-title": "Invest Ophthalmol Vis Sci"}, {"issue": "3", "key": "17_CR17", "doi-asserted-by": "publisher", "first-page": "190", "DOI": "10.1097/ICU.0b013e32833866c8", "volume": "21", "author": "NL Mata", "year": "2010", "unstructured": "Mata NL, Vogel R (2010) Pharmacologic treatment of atrophic age-related macular degeneration. Curr Opin Ophthalmol 21(3):190\u2013196", "journal-title": "Curr Opin Ophthalmol"}, {"issue": "4", "key": "17_CR18", "doi-asserted-by": "publisher", "first-page": "402", "DOI": "10.1001/archophthalmol.2009.9", "volume": "127", "author": "M Saylor", "year": "2009", "unstructured": "Saylor M, McLoon LK, Harrison AR et al (2009) Experimental and clinical evidence for brimonidine as an optic nerve and retinal neuroprotective agent: an evidence-based review. Arch Ophthalmol 127(4):402\u2013406", "journal-title": "Arch Ophthalmol"}, {"issue": "3", "key": "17_CR19", "doi-asserted-by": "publisher", "first-page": "385", "DOI": "10.1097/IAE.0b013e318164a907", "volume": "28", "author": "S Schmitz-Valckenberg", "year": "2008", "unstructured": "Schmitz-Valckenberg S, Holz FG, Bird AC et al (2008) Fundus autofluorescence imaging: review and perspectives. Retina 28(3):385\u2013409", "journal-title": "Retina"}, {"issue": "12", "key": "17_CR20", "doi-asserted-by": "publisher", "first-page": "4393", "DOI": "10.1167/iovs.05-0820", "volume": "46", "author": "RA Radu", "year": "2005", "unstructured": "Radu RA, Han Y, Bui TV et al (2005) Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: a potential therapy for treatment of lipofuscin-based retinal diseases. Invest Ophthalmol Vis Sci 46(12):4393\u20134401", "journal-title": "Invest Ophthalmol Vis Sci"}, {"key": "17_CR21", "doi-asserted-by": "crossref", "first-page": "E", "DOI": "10.1167/iovs.08-2666", "volume": "50", "author": "R Kubota", "year": "2009", "unstructured": "Kubota R, Birch D, David R (2009) Phase 1, dose-escalating study of the safety, tolerability, and pharmacokinetics of ACU-4429 in healthy volunteers. Invest Ophthalmol Vis Sci 50:E-Abstract 5009", "journal-title": "Invest Ophthalmol Vis Sci"}, {"issue": "18", "key": "17_CR22", "doi-asserted-by": "publisher", "first-page": "11830", "DOI": "10.1073/pnas.192203399", "volume": "99", "author": "LV Johnson", "year": "2002", "unstructured": "Johnson LV, Leitner WP, Rivest AJ et al (2002) The Alzheimer\u2019s A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci USA 99(18):11830\u201311835", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "3", "key": "17_CR23", "doi-asserted-by": "publisher", "first-page": "339", "DOI": "10.1016/j.visres.2007.07.025", "volume": "48", "author": "JD Ding", "year": "2008", "unstructured": "Ding JD, Lin J, Mace BE et al (2008) Targeting age-related macular degeneration with Alzheimer\u2019s disease based immunotherapies: anti-amyloid-beta antibody attenuates pathologies in an age-related macular degeneration mouse model. Vision Res 48(3):339\u2013345", "journal-title": "Vision Res"}, {"issue": "2", "key": "17_CR24", "doi-asserted-by": "publisher", "first-page": "115", "DOI": "10.1016/S0039-6257(00)00140-5", "volume": "45", "author": "S Beatty", "year": "2000", "unstructured": "Beatty S, Koh H, Phil M et al (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45(2):115\u2013134", "journal-title": "Surv Ophthalmol"}, {"issue": "12", "key": "17_CR25", "doi-asserted-by": "publisher", "first-page": "2224", "DOI": "10.1016/S0161-6420(00)00409-7", "volume": "107", "author": "Age-Related Eye Disease Study Research Group", "year": "2000", "unstructured": "Group Age-Related Eye Disease Study Research (2000) Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study report number 3. Ophthalmology 107(12):2224\u20132232", "journal-title": "Ophthalmology"}, {"issue": "4", "key": "17_CR26", "doi-asserted-by": "publisher", "first-page": "1900", "DOI": "10.1167/iovs.06-1057", "volume": "48", "author": "M Tanito", "year": "2007", "unstructured": "Tanito M, Li F, Elliott MH et al (2007) Protective effect of TEMPOL derivatives against light-induced retinal damage in rats. Invest Ophthalmol Vis Sci 48(4):1900\u20131905", "journal-title": "Invest Ophthalmol Vis Sci"}, {"key": "17_CR27", "first-page": "E", "volume": "51", "author": "P Sternberg", "year": "2010", "unstructured": "Sternberg P, Rosenfeld PJ, Slakter JS et al (2010) Topical OT-551 for treating geographic atrophy: Phase II results. Invest Ophthalmol Vis Sci 51:E-Abstract 6416", "journal-title": "Invest Ophthalmol Vis Sci"}, {"key": "17_CR28", "first-page": "E", "volume": "51", "author": "WT Wong", "year": "2010", "unstructured": "Wong WT, Kam W, Cunningham D et al (2010) Topical administration of anti-oxidant, OT-551 for the treatment of geographic atrophy: results of a phase I/II clinical trial. Invest Ophthalmol Vis Sci 51:E-Abstract 6418", "journal-title": "Invest Ophthalmol Vis Sci"}, {"issue": "3", "key": "17_CR29", "doi-asserted-by": "publisher", "first-page": "349", "DOI": "10.1001/archophthalmol.2010.18", "volume": "128", "author": "KM Gehrs", "year": "2010", "unstructured": "Gehrs KM, Jackson JR, Brown EN et al (2010) Complement, age-related macular degeneration and a vision of the future. Arch Ophthalmol 128(3):349\u2013358", "journal-title": "Arch Ophthalmol"}, {"issue": "2", "key": "17_CR30", "doi-asserted-by": "publisher", "first-page": "95", "DOI": "10.1016/j.preteyeres.2009.11.003", "volume": "29", "author": "DH Anderson", "year": "2010", "unstructured": "Anderson DH, Radeke MJ, Gallo NB et al (2010) The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res 29(2):95\u2013112", "journal-title": "Prog Retin Eye Res"}, {"issue": "10", "key": "17_CR31", "doi-asserted-by": "publisher", "first-page": "5336", "DOI": "10.1167/iovs.10-5322", "volume": "51", "author": "JM Skeie", "year": "2010", "unstructured": "Skeie JM, Fingert J, Russell S et al (2010) Complement component C5a activates Icam-1 expression on human choroidal endothelial cells. Invest Ophthalmol Vis Sci 2010 Oct;51(10):5336-42", "journal-title": "Invest Ophthalmol Vis Sci"}, {"issue": "2", "key": "17_CR32", "doi-asserted-by": "publisher", "first-page": "97", "DOI": "10.1007/s00281-008-0112-9", "volume": "30", "author": "M Patel", "year": "2008", "unstructured": "Patel M, Chan CC (2008) Immunopathological aspects of age-related macular degeneration. Semin Immunopathol 30(2):97\u2013110", "journal-title": "Semin Immunopathol"}, {"issue": "8", "key": "17_CR33", "doi-asserted-by": "publisher", "first-page": "1554", "DOI": "10.1016/j.ophtha.2009.12.012", "volume": "117", "author": "ML Klein", "year": "2010", "unstructured": "Klein ML, Ferris FL 3rd, Francis PJ et al (2010) Progression of geographic atrophy and genotype in age-related macular degeneration. Ophthalmology 2010 Aug;117(8):1554\u20139, 1559.e1", "journal-title": "Ophthalmology"}, {"issue": "10", "key": "17_CR34", "doi-asserted-by": "publisher", "first-page": "e7418", "DOI": "10.1371/journal.pone.0007418", "volume": "4", "author": "HP Scholl", "year": "2009", "unstructured": "Scholl HP, Fleckenstein M, Fritsche LG et al (2009) CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD. PLoS One 4(10):e7418", "journal-title": "PLoS One"}, {"issue": "7", "key": "17_CR35", "doi-asserted-by": "publisher", "first-page": "2328", "DOI": "10.1073/pnas.0408835103", "volume": "103", "author": "M Nozaki", "year": "2006", "unstructured": "Nozaki M, Raisler BJ, Sakurai E et al (2006) Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci USA 103(7):2328\u20132333", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "17_CR36", "unstructured": "Holers VM et al (2009) TT30, a novel human protein therapeutic, selectively modulates the complement alternative pathway by targeted supplementation of local factor H activity. In: 51st Annual Meeting of the American Society of Hematology New Orleans"}, {"key": "17_CR37", "unstructured": "Risitano AM et al (2009) TT30, a novel regulator of the complement alternative pathway (CAP), inhibits hemolysis of paroxysmal nocturnal hemoglobinuria (PNH) erythrocytes and prevents upstream C3 binding on their surface in an in vitro model. In: 51st Annual Meeting of the American Society of Hematology New Orleans"}, {"issue": "11", "key": "17_CR38", "doi-asserted-by": "publisher", "first-page": "1011", "DOI": "10.1080/02713680802484637", "volume": "33", "author": "G Landa", "year": "2008", "unstructured": "Landa G, Butovsky O, Shoshani J et al (2008) Weekly vaccination with Copaxone (glatiramer acetate) as a potential therapy for dry age-related macular degeneration. Curr Eye Res 33(11):1011\u20131013", "journal-title": "Curr Eye Res"}], "container-title": ["Age-related Macular Degeneration"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-3-642-22107-1_17", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 7]], "date-time": "2019-05-07T06:44:50Z", "timestamp": 1557211490000}, "score": 42.74997, "issued": {"date-parts": [[2012, 4, 20]]}, "ISBN": ["9783642221064", "9783642221071"], "references-count": 38, "URL": "http://dx.doi.org/10.1007/978-3-642-22107-1_17", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T10:23:14Z", "timestamp": 1575282194101}, "reference-count": 30, "publisher": "Elsevier BV", "issue": "10", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2018, 10, 1]], "date-time": "2018-10-01T00:00:00Z", "timestamp": 1538352000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Ophthalmology Retina"], "published-print": {"date-parts": [[2018, 10]]}, "DOI": "10.1016/j.oret.2018.03.001", "type": "journal-article", "created": {"date-parts": [[2018, 4, 18]], "date-time": "2018-04-18T00:07:12Z", "timestamp": 1524010032000}, "page": "1028-1040", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 5, "title": ["A Randomized Phase 2 Study of an Anti\u2013Amyloid \u03b2 Monoclonal Antibody in Geographic Atrophy Secondary to Age-Related Macular Degeneration"], "prefix": "10.1016", "volume": "2", "author": [{"given": "Philip J.", "family": "Rosenfeld", "sequence": "first", "affiliation": []}, {"given": "Brian", "family": "Berger", "sequence": "additional", "affiliation": []}, {"given": "Elias", "family": "Reichel", "sequence": "additional", "affiliation": []}, {"given": "Ronald P.", "family": "Danis", "sequence": "additional", "affiliation": []}, {"given": "Angie", "family": "Gress", "sequence": "additional", "affiliation": []}, {"given": "Li", "family": "Ye", "sequence": "additional", "affiliation": []}, {"given": "Mindy", "family": "Magee", "sequence": "additional", "affiliation": []}, {"given": "Laura R.", "family": "Parham", "sequence": "additional", "affiliation": []}, {"given": "Megan M.", "family": "McLaughlin", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Ophthalmology Retina"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S2468653017307418?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S2468653017307418?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 3]], "date-time": "2018-10-03T09:30:49Z", "timestamp": 1538559049000}, "score": 42.09406, "issued": {"date-parts": [[2018, 10]]}, "references-count": 30, "journal-issue": {"published-print": {"date-parts": [[2018, 10]]}, "issue": "10"}, "alternative-id": ["S2468653017307418"], "URL": "http://dx.doi.org/10.1016/j.oret.2018.03.001", "ISSN": ["2468-6530"], "issn-type": [{"value": "2468-6530", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "A Randomized Phase 2 Study of an Anti\u2013Amyloid \u03b2 Monoclonal Antibody in Geographic Atrophy Secondary to Age-Related Macular Degeneration", "name": "articletitle", "label": "Article Title"}, {"value": "Ophthalmology Retina", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.oret.2018.03.001", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "\u00a9 2018 Published by Elsevier Inc. on behalf of the American Academy of Ophthalmology", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T23:38:04Z", "timestamp": 1575502684953}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2014, 5, 1]], "date-time": "2014-05-01T00:00:00Z", "timestamp": 1398902400000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "https://www.elsevier.com/open-access/userlicense/1.0/", "start": {"date-parts": [[2015, 5, 1]], "date-time": "2015-05-01T00:00:00Z", "timestamp": 1430438400000}, "delay-in-days": 365, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Value in Health"], "published-print": {"date-parts": [[2014, 5]]}, "DOI": "10.1016/j.jval.2014.03.867", "type": "journal-article", "created": {"date-parts": [[2014, 7, 11]], "date-time": "2014-07-11T08:03:55Z", "timestamp": 1405065835000}, "page": "A149", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Treatment Patterns Of Neovascular Age-Related Macular Degeneration"], "prefix": "10.1016", "volume": "17", "author": [{"given": "P.U", "family": "Dugel", "sequence": "first", "affiliation": []}, {"given": "R.J.", "family": "Arnold", "sequence": "additional", "affiliation": []}, {"given": "A.J.", "family": "Layton", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Value in Health"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1098301514009188?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1098301514009188?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 1]], "date-time": "2018-10-01T17:51:21Z", "timestamp": 1538416281000}, "score": 41.727154, "issued": {"date-parts": [[2014, 5]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2014, 5]]}, "issue": "3"}, "alternative-id": ["S1098301514009188"], "URL": "http://dx.doi.org/10.1016/j.jval.2014.03.867", "ISSN": ["1098-3015"], "issn-type": [{"value": "1098-3015", "type": "print"}], "subject": ["Public Health, Environmental and Occupational Health", "Health Policy"]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T09:51:48Z", "timestamp": 1574416308624}, "reference-count": 0, "publisher": "Informa Healthcare", "isbn-type": [{"value": "9780824706821", "type": "print"}, {"value": "9780203909157", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2002, 8, 14]]}, "DOI": "10.1201/9780203909157.pt5", "type": "book-chapter", "created": {"date-parts": [[2010, 3, 7]], "date-time": "2010-03-07T21:54:49Z", "timestamp": 1267998889000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Submacular Surgery For Patients With Age- Related Macular Degeneration"], "prefix": "10.1201", "author": [{"given": "P", "family": "Rao", "sequence": "first", "affiliation": []}, {"given": "Matthew", "family": "Thomas", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2010, 3, 7]]}, "container-title": ["Age-Related Macular Degeneration, Second Edition"], "deposited": {"date-parts": [[2010, 3, 7]], "date-time": "2010-03-07T21:54:53Z", "timestamp": 1267998893000}, "score": 41.35545, "issued": {"date-parts": [[2002, 8, 14]]}, "ISBN": ["9780824706821", "9780203909157"], "references-count": 0, "alternative-id": ["10.1201/9780203909157.pt5", "10.1201/9780203909157"], "URL": "http://dx.doi.org/10.1201/9780203909157.pt5"}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T03:30:06Z", "timestamp": 1574479806076}, "reference-count": 0, "publisher": "American Medical Association (AMA)", "issue": "8", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Arch Ophthalmol"], "published-print": {"date-parts": [[2002, 8, 1]]}, "DOI": "10.1001/archopht.120.8.1029", "type": "journal-article", "created": {"date-parts": [[2012, 6, 5]], "date-time": "2012-06-05T06:41:31Z", "timestamp": 1338878491000}, "page": "1029", "source": "Crossref", "is-referenced-by-count": 54, "title": ["Visual Outcomes in the Subfoveal Radiotherapy Study"], "prefix": "10.1001", "volume": "120", "author": [{"given": "P. M.", "family": "Hart", "sequence": "first", "affiliation": []}], "member": "10", "container-title": ["Archives of Ophthalmology"], "language": "en", "deposited": {"date-parts": [[2013, 11, 6]], "date-time": "2013-11-06T05:33:10Z", "timestamp": 1383715990000}, "score": 41.247562, "subtitle": ["A Randomized Controlled Trial of Teletherapy for Age-Related Macular Degeneration"], "issued": {"date-parts": [[2002, 8, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2002, 8, 1]]}, "issue": "8"}, "URL": "http://dx.doi.org/10.1001/archopht.120.8.1029", "ISSN": ["0003-9950"], "issn-type": [{"value": "0003-9950", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T18:22:37Z", "timestamp": 1574706157100}, "reference-count": 56, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2016, 10, 7]], "date-time": "2016-10-07T00:00:00Z", "timestamp": 1475798400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Eye"], "published-print": {"date-parts": [[2017, 1]]}, "DOI": "10.1038/eye.2016.208", "type": "journal-article", "created": {"date-parts": [[2016, 10, 7]], "date-time": "2016-10-07T13:04:23Z", "timestamp": 1475845463000}, "page": "1-9", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 21, "title": ["Risk of geographic atrophy in age-related macular degeneration patients treated with intravitreal anti-VEGF agents"], "prefix": "10.1038", "volume": "31", "author": [{"given": "M", "family": "Gemenetzi", "sequence": "first", "affiliation": []}, {"given": "A J", "family": "Lotery", "sequence": "additional", "affiliation": []}, {"given": "P J", "family": "Patel", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2016, 10, 7]]}, "reference": [{"key": "BFeye2016208_CR1", "doi-asserted-by": "publisher", "first-page": "185", "DOI": "10.1159/000443209", "volume": "55", "author": "P Kaszubski", "year": "2016", "unstructured": "Kaszubski P, Ben Ami T, Saade C, Smith RT . Geographic atrophy and choroidal neovascularization in the same eye: a review. Ophthalmic Res 2016; 55: 185\u2013193.", "journal-title": "Ophthalmic Res"}, {"key": "BFeye2016208_CR2", "doi-asserted-by": "publisher", "first-page": "150", "DOI": "10.1016/j.ophtha.2013.08.015", "volume": "121", "author": "JE Grunwald", "year": "2014", "unstructured": "Grunwald JE, Daniel E, Huang J, Ying GS, Maguire MG, Toth CA et al. Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials. Ophthalmology 2014; 121: 150\u2013161.", "journal-title": "Ophthalmology"}, {"key": "BFeye2016208_CR3", "doi-asserted-by": "publisher", "first-page": "809", "DOI": "10.1016/j.ophtha.2014.11.007", "volume": "122", "author": "JE Grunwald", "year": "2015", "unstructured": "Grunwald JE, Pistilli M, Ying G, Maguire MG, Daniel E, Martin DF et al. Growth of geographic atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). Ophthalmology 2015; 122: 809\u2013816.", "journal-title": "Ophthalmology"}, {"key": "BFeye2016208_CR4", "doi-asserted-by": "publisher", "first-page": "1258", "DOI": "10.1016/S0140-6736(13)61501-9", "volume": "382", "author": "U Chakravarthy", "year": "2013", "unstructured": "Chakravarthy U, Harding SP, Rogers CA, Downes SM, Lotery AJ, Culliford LA et al. Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial. Lancet 2013; 382: 1258\u20131267.", "journal-title": "Lancet"}, {"key": "BFeye2016208_CR5", "doi-asserted-by": "publisher", "first-page": "321", "DOI": "10.1001/archopht.123.3.321", "volume": "123", "author": "JM Seddon", "year": "2005", "unstructured": "Seddon JM, Cote J, Page WF, Aggen SH, Neale MC . The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol 2005; 123: 321.", "journal-title": "Arch Ophthalmol"}, {"key": "BFeye2016208_CR6", "doi-asserted-by": "publisher", "first-page": "730", "DOI": "10.1016/S0161-6420(01)01049-1", "volume": "109", "author": "CJ Hammond", "year": "2002", "unstructured": "Hammond CJ, Webster AR, Snieder H, Bird AC, Gilbert CE, Spector TD . Genetic influence on early age-related maculopathy: a twin study. Ophthalmology 2002; 109: 730\u2013736.", "journal-title": "Ophthalmology"}, {"key": "BFeye2016208_CR7", "doi-asserted-by": "publisher", "first-page": "9", "DOI": "10.1167/tvst.5.2.9", "volume": "5", "author": "JW Miller", "year": "2016", "unstructured": "Miller JW . VEGF: from discovery to therapy:the champalimaud award lecture. Transl Vis Sci Technol 2016; 5: 9.", "journal-title": "Transl Vis Sci Technol"}, {"key": "BFeye2016208_CR8", "first-page": "46", "volume": "20", "author": "DL Kent", "year": "2014", "unstructured": "Kent DL . Age-related macular degeneration: beyond anti-angiogenesis. Mol Vis 2014; 20: 46\u201355.", "journal-title": "Mol Vis"}, {"key": "BFeye2016208_CR9", "first-page": "27", "volume": "5", "author": "WR Green", "year": "1999", "unstructured": "Green WR . Histopathology of age-related macular degeneration. Mol Vis 1999; 5: 27.", "journal-title": "Mol Vis"}, {"key": "BFeye2016208_CR10", "doi-asserted-by": "publisher", "first-page": "910", "DOI": "10.1016/S0161-6420(99)00509-6", "volume": "106", "author": "JS Sunness", "year": "1999", "unstructured": "Sunness JS, Gonzalez-Baron J, Bressler NM, Hawkins B, Applegate CA . The development of choroidal neovascularization in eyes with the geographic atrophy form of age-related macular degeneration. Ophthalmology 1999; 106: 910\u2013919.", "journal-title": "Ophthalmology"}, {"key": "BFeye2016208_CR11", "doi-asserted-by": "publisher", "first-page": "1541", "DOI": "10.1016/S0161-6420(89)32694-7", "volume": "96", "author": "H Schatz", "year": "1989", "unstructured": "Schatz H, McDonald HR . Atrophic macular degeneration. Rate of spread of geographic atrophy and visual loss. Ophthalmology 1989; 96: 1541\u20131551.", "journal-title": "Ophthalmology"}, {"key": "BFeye2016208_CR12", "first-page": "180", "volume": "75", "author": "WR Green", "year": "1977", "unstructured": "Green WR, Key SN . 3d. Senile macular degeneration: a histopathologic study. Trans Am Ophthalmol Soc 1977; 75: 180\u2013254.", "journal-title": "Trans Am Ophthalmol Soc"}, {"key": "BFeye2016208_CR13", "doi-asserted-by": "publisher", "first-page": "552", "DOI": "10.1038/eye.1988.106", "volume": "2", "author": "JP Sarks", "year": "1988", "unstructured": "Sarks JP, Sarks SH, Killingsworth MC . Evolution of geographic atrophy of the retinal pigment epithelium. Eye 1988; 2: 552\u2013577.", "journal-title": "Eye"}, {"key": "BFeye2016208_CR14", "doi-asserted-by": "publisher", "first-page": "18751", "DOI": "10.1073/pnas.0905010106", "volume": "106", "author": "M Saint-Geniez", "year": "2009", "unstructured": "Saint-Geniez M, Kurihara T, Sekiyama E, Maldonado AE, D\u2019Amore PA . An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. Proc Natl Acad Sci USA 2009; 106: 18751\u201318756.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFeye2016208_CR15", "doi-asserted-by": "publisher", "first-page": "295", "DOI": "10.1016/j.mam.2012.04.005", "volume": "33", "author": "I Bhutto", "year": "2012", "unstructured": "Bhutto I, Lutty G . Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch\u2019s membrane/choriocapillaris complex. Mol Aspects Med 2012; 33: 295\u2013317.", "journal-title": "Mol Aspects Med"}, {"key": "BFeye2016208_CR16", "doi-asserted-by": "publisher", "first-page": "4982", "DOI": "10.1167/iovs.09-3639", "volume": "50", "author": "DS McLeod", "year": "2009", "unstructured": "McLeod DS, Grebe R, Bhutto I, Merges C, Baba T, Lutty GA . Relationship between RPE and choriocapillaris in age-related macular degeneration. Invest Ophthalmol Vis Sci 2009; 50: 4982\u20134991.", "journal-title": "Invest Ophthalmol Vis Sci"}, {"key": "BFeye2016208_CR17", "doi-asserted-by": "publisher", "first-page": "496", "DOI": "10.1016/j.ajo.2008.05.032", "volume": "146", "author": "RF Spaide", "year": "2008", "unstructured": "Spaide RF, Koizumi H, Pozzoni MC . Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 2008; 146: 496\u2013500.", "journal-title": "Am J Ophthalmol"}, {"key": "BFeye2016208_CR18", "doi-asserted-by": "publisher", "first-page": "e52", "DOI": "10.1111/j.1755-3768.2010.01958.x", "volume": "89", "author": "YG Kim", "year": "2011", "unstructured": "Kim YG, Baek SH, Moon SW, Lee HK, Kim US . Analysis of spectral domain optical coherence tomography findings in occult macular dystrophy. Acta Ophthalmol 2011; 89: e52\u2013e56.", "journal-title": "Acta Ophthalmol"}, {"key": "BFeye2016208_CR19", "first-page": "3799", "volume": "35", "author": "DS McLeod", "year": "1994", "unstructured": "McLeod DS, Lutty GA . High resolution histologic analysis of the human choroidal vasculature. Invest Ophthalmol Vis Sci 1994; 35: 3799\u20133811.", "journal-title": "Invest Ophthalmol Vis Sci"}, {"key": "BFeye2016208_CR20", "first-page": "1986", "volume": "43", "author": "DS McLeod", "year": "2002", "unstructured": "McLeod DS, Taomoto M, Otsuji T, Green WR, Sunness JS, Lutty GA . Quantifying changes in RPE and choriocapillaris in eyes with age-related macular degeneration. Invest Ophthalmol Vis Sci 2002; 43: 1986\u20131993.", "journal-title": "Invest Ophthalmol Vis Sci"}, {"key": "BFeye2016208_CR21", "doi-asserted-by": "publisher", "first-page": "720", "DOI": "10.1136/bjophthalmol-2015-308290", "volume": "100", "author": "I Bhutto", "year": "2016", "unstructured": "Bhutto I, McLeod DS, Jing T, Sunness JS, Seddon JM, Lutty G . Increased choroidal mast cells and their degranulation in age-related macular degeneration. Br J Ophthalmol 2016; 100: 720\u2013726.", "journal-title": "Br J Ophthalmol"}, {"key": "BFeye2016208_CR22", "doi-asserted-by": "publisher", "first-page": "1606", "DOI": "10.1167/iovs.10-6476", "volume": "52", "author": "RF Mullins", "year": "2011", "unstructured": "Mullins RF, Johnson MN, Faidley EA, Skeie JM, Huang J . Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration. Invest Ophthalmol Vis Sci 2011b; 52: 1606\u20131612.", "journal-title": "Invest Ophthalmol Vis Sci"}, {"key": "BFeye2016208_CR23", "unstructured": "Macular Photocoagulation Study Group. Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Arch Ophthalmol 1993; 111: 1189\u20131199.", "DOI": "10.1001/archopht.1993.01090090041018", "doi-asserted-by": "crossref"}, {"key": "BFeye2016208_CR24", "doi-asserted-by": "publisher", "first-page": "741", "DOI": "10.1001/archopht.1997.01100150743009", "volume": "115", "author": "Macular Photocoagulation Study Group", "year": "1997", "unstructured": "Macular Photocoagulation Study Group. Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol 1997; 115: 741\u2013747.", "journal-title": "Arch Ophthalmol"}, {"key": "BFeye2016208_CR25", "doi-asserted-by": "publisher", "first-page": "692", "DOI": "10.1016/j.ajo.2008.05.050", "volume": "146", "author": "R Klein", "year": "2008", "unstructured": "Klein R, Meuer SM, Knudtson MD, Klein BE . The epidemiology of progression of pure geographic atrophy: the Beaver Dam Eye Study. Am J Ophthalmol 2008; 146: 692\u2013699.", "journal-title": "Am J Ophthalmol"}, {"key": "BFeye2016208_CR26", "doi-asserted-by": "publisher", "first-page": "1106", "DOI": "10.1038/eye.2012.107", "volume": "26", "author": "S Grob", "year": "2012", "unstructured": "Grob S, Luo J, Hughes G, Lee C, Zhou X, Lee J et al. Genetic analysis of simultaneous geographic atrophy and choroidal neovascularization. Eye (Lond) 2012; 26: 1106\u20131113.", "journal-title": "Eye (Lond)"}, {"key": "BFeye2016208_CR27", "unstructured": "Grunwald JE, Pistilli M, Daniel E, Ying G-S, Jaffe GJ, Fine S et al. Size and growth of geographic atrophy during 5 years of follow up in the Comparison of Age related Macular Degeneration Treatment Trials (CATT). ARVO 2016 Abstract No: 4292."}, {"key": "BFeye2016208_CR28", "doi-asserted-by": "publisher", "first-page": "1550", "DOI": "10.1016/S0161-6420(85)33836-8", "volume": "92", "author": "MJ Harris", "year": "1985", "unstructured": "Harris MJ, Robins D, Dieter Jr JM, Fine SL, Guyton DL . Eccentric visual acuity in patients with macular disease. Ophthalmology 1985; 92: 1550\u20131553.", "journal-title": "Ophthalmology"}, {"key": "BFeye2016208_CR29", "doi-asserted-by": "publisher", "first-page": "1837", "DOI": "10.1016/j.ophtha.2015.05.010", "volume": "122", "author": "MC Gillies", "year": "2015", "unstructured": "Gillies MC, Campain A, Barthelmes D, Simpson JM, Arnold JJ, Guymer RH et al. Long-term outcomes of treatment of neovascular age-related macular degeneration-data from an observational study. Ophthalmology 2015; 122: 1837\u20131845.", "journal-title": "Ophthalmology"}, {"key": "BFeye2016208_CR30", "doi-asserted-by": "publisher", "first-page": "2292", "DOI": "10.1016/j.ophtha.2013.03.046", "volume": "120", "author": "S Rofagha", "year": "2013", "unstructured": "Rofagha S, Bhisitkul RB, Boyer DS, Sadda SR, Zhang K, SEVEN-UP Study Group. Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP). Ophthalmology 2013; 120: 2292\u20132299.", "journal-title": "Ophthalmology"}, {"key": "BFeye2016208_CR31", "doi-asserted-by": "publisher", "first-page": "1092", "DOI": "10.1016/j.ophtha.2013.11.031", "volume": "121", "author": "Writing Committee for the UK Age-Related Macular Degeneration EMR Users Group", "year": "2014", "unstructured": "Writing Committee for the UK Age-Related Macular Degeneration EMR Users Group. The neovascular age-related macular degeneration database: multicenter study of 92\u2009976 ranibizumab injections: report 1: visual acuity. Ophthalmology 2014; 121: 1092\u20131101.", "journal-title": "Ophthalmology"}, {"key": "BFeye2016208_CR32", "doi-asserted-by": "publisher", "first-page": "1432", "DOI": "10.1056/NEJMoa062655", "volume": "355", "author": "DM Brown", "year": "2006", "unstructured": "Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006; 355: 1432\u20131444.", "journal-title": "N Engl J Med"}, {"key": "BFeye2016208_CR33", "doi-asserted-by": "publisher", "first-page": "57", "DOI": "10.1016/j.ophtha.2008.10.018", "volume": "116", "author": "DM Brown", "year": "2009", "unstructured": "Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T et al. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology 2009; 116: 57\u201365.", "journal-title": "Ophthalmology"}, {"key": "BFeye2016208_CR34", "doi-asserted-by": "publisher", "first-page": "1419", "DOI": "10.1056/NEJMoa054481", "volume": "355", "author": "PJ Rosenfeld", "year": "2006", "unstructured": "Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355: 1419\u20131431.", "journal-title": "N Engl J Med"}, {"key": "BFeye2016208_CR35", "doi-asserted-by": "publisher", "first-page": "1175", "DOI": "10.1016/j.ophtha.2011.12.016", "volume": "119", "author": "MA Singer", "year": "2012", "unstructured": "Singer MA, Awh CC, Sadda S, Freeman WR, Antoszyk AN, Wong P et al. HORIZON: an openlabel extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology 2012; 119: 1175\u20131183.", "journal-title": "Ophthalmology"}, {"key": "BFeye2016208_CR36", "doi-asserted-by": "publisher", "first-page": "1269", "DOI": "10.1016/j.ophtha.2016.01.033", "volume": "123", "author": "RB Bhisitkul", "year": "2016", "unstructured": "Bhisitkul RB, Desai SJ, Boyer DS, Sadda SVR, Zhang K . Fellow eye comparisons for 7-year outcomes in ranibizumab-treated AMD subjects from ANCHOR, MARINA, and HORIZON (SEVEN-UP Study). Ophthalmology 2016; 123: 1269\u20131277.", "journal-title": "Ophthalmology"}, {"key": "BFeye2016208_CR37", "unstructured": "Sadda S, Tuomi L, Ding B, Hopkins JJ . Development of Atrophy in Neovascular AMD Treated with Anti-VEGF Therapy: Results of the HARBOR Study. Paper Presented at AAO Annual Meeting, Retina Subspecialty Day; 17 October 2014; Chicago, IL, USA."}, {"key": "BFeye2016208_CR38", "doi-asserted-by": "publisher", "first-page": "13", "DOI": "10.1097/IAE.0b013e3182657fff", "volume": "33", "author": "N Lois", "year": "2013", "unstructured": "Lois N, McBain V, Abdelkader E, Scott NW, Kumari R . Retinal pigment epithelial atrophy in patients with exudative age-related macular degeneration undergoing anti-vascular endothelial growth factor therapy. Retina 2013; 33: 13\u201322.", "journal-title": "Retina"}, {"key": "BFeye2016208_CR39", "doi-asserted-by": "publisher", "first-page": "1308", "DOI": "10.1097/IAE.0000000000000081", "volume": "34", "author": "M Young", "year": "2014", "unstructured": "Young M, Chui L, Fallah N, Or C, Merkur AB, Kirker AW et al. Exacerbation of choroidal and retinal pigment epithelial atrophy after anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration. Retina 2014; 34: 1308\u20131315.", "journal-title": "Retina"}, {"key": "BFeye2016208_CR40", "doi-asserted-by": "publisher", "first-page": "176", "DOI": "10.1097/IAE.0000000000000374", "volume": "35", "author": "L Xu", "year": "2015", "unstructured": "Xu L, Mrejen S, Jung JJ, Gallego-Pinazo R, Thompson D, Marsiglia M et al. Geographic atrophy in patients receiving anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Retina 2015; 35: 176\u2013186.", "journal-title": "Retina"}, {"key": "BFeye2016208_CR41", "doi-asserted-by": "publisher", "first-page": "1368", "DOI": "10.1097/IAE.0b013e3181d50cbf", "volume": "30", "author": "M Engelbert", "year": "2010", "unstructured": "Engelbert M, Zweifel SA, Freund KB . Long-term follow-up for type 1 (subretinal pigment epithelium) neovascularization using a modified \u2018treat and extend\u2019 dosing regimen of intravitreal antivascular endothelial growth factor therapy. Retina 2010; 30: 1368\u20131375.", "journal-title": "Retina"}, {"key": "BFeye2016208_CR42", "doi-asserted-by": "publisher", "first-page": "496", "DOI": "10.1016/j.ajo.2003.09.042", "volume": "137", "author": "HE Grossniklaus", "year": "2004", "unstructured": "Grossniklaus HE, Green WR . Choroidal neovascularization. Am J Ophthalmol 2004; 137: 496\u2013503.", "journal-title": "Am J Ophthalmol"}, {"key": "BFeye2016208_CR43", "doi-asserted-by": "publisher", "first-page": "1220", "DOI": "10.1001/archopht.1991.01080090044025", "volume": "109", "author": "Macular Photocoagulation Study Group", "year": "1991", "unstructured": "Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesion in age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol 1991; 109: 1220\u20131231.", "journal-title": "Arch Ophthalmol"}, {"key": "BFeye2016208_CR44", "doi-asserted-by": "publisher", "first-page": "400", "DOI": "10.1001/archopht.1996.01100130396006", "volume": "114", "author": "Macular Photocoagulation Study Group", "year": "1996", "unstructured": "Macular Photocoagulation Study Group. Occult choroidal neovascularization. Influence on visual outcome in patients with age-related macular degeneration. Arch Ophthalmol 1996; 114: 400\u2013412 Erratum in Arch Ophthalmol 1996; 114: 1023..", "journal-title": "Arch Ophthalmol"}, {"key": "BFeye2016208_CR45", "doi-asserted-by": "publisher", "first-page": "258", "DOI": "10.1016/S0002-9394(14)72951-4", "volume": "118", "author": "JD Gass", "year": "1994", "unstructured": "Gass JD . Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes. Am J Ophthalmol 1994; 118: 258\u2013298.", "journal-title": "Am J Ophthalmol"}, {"key": "BFeye2016208_CR46", "doi-asserted-by": "publisher", "first-page": "1333", "DOI": "10.1097/IAE.0b013e3181e7976b", "volume": "30", "author": "K Freund", "year": "2010", "unstructured": "Freund K, Bailey MD, Zweifel SA, Engelbert M . Do we need a new classification for choroidal neovascularization in age-related macular degeneration? Retina 2010; 30: 1333\u20131349.", "journal-title": "Retina"}, {"key": "BFeye2016208_CR47", "doi-asserted-by": "publisher", "first-page": "1843", "DOI": "10.1097/IAE.0000000000001059", "volume": "36", "author": "NS Abdelfattah", "year": "2016", "unstructured": "Abdelfattah NS, Zhang H, Boyer DS, Sadda SR . Progression of macular atrophy in patients with age-related macular degeneration undergoing antivascular endothelial growth factor therapy. Retina 2016; 36: 1843\u20131850.", "journal-title": "Retina"}, {"key": "BFeye2016208_CR48", "doi-asserted-by": "publisher", "first-page": "966", "DOI": "10.1097/IAE.0000000000000460", "volume": "35", "author": "M Marsiglia", "year": "2015", "unstructured": "Marsiglia M, Boddu S, Chen CY, Jung JJ, Mrejen S, Gallego-Pinazo R et al. Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration. Retina 2015; 35: 966\u2013974.", "journal-title": "Retina"}, {"key": "BFeye2016208_CR49", "doi-asserted-by": "publisher", "first-page": "1169", "DOI": "10.1016/j.ophtha.2009.10.044", "volume": "117", "author": "S Schmitz-Valckenberg", "year": "2010", "unstructured": "Schmitz-Valckenberg S, Steinberg JS, Fleckenstein M, Visvalingam S, Brinkmann CK, Holz FG . Combined confocal scanning laser ophthalmoscopy and spectral-domain optical coherence tomography imaging of reticular drusen associated with age-related macular degeneration. Ophthalmology 2010; 117: 1169\u20131176.", "journal-title": "Ophthalmology"}, {"key": "BFeye2016208_CR50", "doi-asserted-by": "publisher", "first-page": "545", "DOI": "10.1016/j.ophtha.2013.09.026", "volume": "121", "author": "S Mrejen", "year": "2014", "unstructured": "Mrejen S, Sato T, Curcio CA, Spaide RF . Assessing the cone photoreceptor mosaic in eyes with pseudodrusen and soft drusen in vivo using adaptive optics imaging. Ophthalmology 2014; 121: 545\u2013555.", "journal-title": "Ophthalmology"}, {"key": "BFeye2016208_CR51", "doi-asserted-by": "publisher", "first-page": "1775", "DOI": "10.1016/j.ophtha.2010.01.027", "volume": "117", "author": "SA Zweifel", "year": "2010", "unstructured": "Zweifel SA, Imamura Y, Spaide TC, Fujiwara T, Spaide RF . Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration. Ophthalmology 2010; 117: 1775\u20131781.", "journal-title": "Ophthalmology"}, {"key": "BFeye2016208_CR52", "doi-asserted-by": "publisher", "first-page": "303", "DOI": "10.1016/j.ophtha.2009.07.014", "volume": "117", "author": "SA Zweifel", "year": "2010", "unstructured": "Zweifel SA, Spaide RF, Curcio CA, Malek G, Imamura Y . Reticular pseudodrusen are subretinal drusenoid deposits. Ophthalmology 2010; 117: 303\u2013312.", "journal-title": "Ophthalmology"}, {"key": "BFeye2016208_CR53", "doi-asserted-by": "publisher", "first-page": "1441", "DOI": "10.1097/IAE.0b013e3181ee5ce8", "volume": "30", "author": "RF Spaide", "year": "2010", "unstructured": "Spaide RF, Curcio CA . Drusen characterization with multimodal imaging. Retina 2010; 30: 1441\u20131454.", "journal-title": "Retina"}, {"key": "BFeye2016208_CR54", "doi-asserted-by": "publisher", "first-page": "1519", "DOI": "10.1016/S0161-6420(93)31466-1", "volume": "100", "author": "WR Green", "year": "1993", "unstructured": "Green WR, Enger C . Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture. Ophthalmology 1993; 100: 1519\u20131535.", "journal-title": "Ophthalmology"}, {"key": "BFeye2016208_CR55", "first-page": "747", "volume": "9", "author": "DL Kent", "year": "2003", "unstructured": "Kent DL, Sheridan C . Choroidal neovascularization: a wound healing perspective. Mol Vis 2003; 9: 747\u2013755.", "journal-title": "Mol Vis"}, {"key": "BFeye2016208_CR56", "doi-asserted-by": "publisher", "first-page": "31", "DOI": "10.1186/s12886-016-0207-3", "volume": "16", "author": "JJ Arnold", "year": "2016", "unstructured": "Arnold JJ, Markey CM, Kurstjens NP, Guymer RH . The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration - a phase IV randomised clinical trial with ranibizumab: the FLUID study. BMC Ophthalmology 2016; 16: 31.", "journal-title": "BMC Ophthalmology"}], "container-title": ["Eye"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/eye2016208.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/eye2016208", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/eye2016208.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 14]], "date-time": "2019-04-14T08:31:21Z", "timestamp": 1555230681000}, "score": 40.942505, "issued": {"date-parts": [[2016, 10, 7]]}, "references-count": 56, "journal-issue": {"published-print": {"date-parts": [[2017, 1]]}, "issue": "1"}, "alternative-id": ["BFeye2016208"], "URL": "http://dx.doi.org/10.1038/eye.2016.208", "relation": {"cites": []}, "ISSN": ["0950-222X", "1476-5454"], "issn-type": [{"value": "0950-222X", "type": "print"}, {"value": "1476-5454", "type": "electronic"}], "assertion": [{"value": "23 May 2016", "order": 1, "name": "received", "label": "Received", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "20 August 2016", "order": 2, "name": "accepted", "label": "Accepted", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "7 October 2016", "order": 3, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "The authors declare no conflict of interest.", "order": 1, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Competing interests"}}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T10:49:13Z", "timestamp": 1574246953528}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Retina"], "published-print": {"date-parts": [[1999]]}, "DOI": "10.1097/00006982-199919050-00036", "type": "journal-article", "created": {"date-parts": [[2006, 11, 22]], "date-time": "2006-11-22T22:32:29Z", "timestamp": 1164234749000}, "page": "482", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Transplantation of RPE in Age-related Macular Degeneration"], "prefix": "10.1097", "volume": "19", "author": [{"given": "P. V.", "family": "Algvere", "sequence": "first", "affiliation": []}, {"given": "L.", "family": "Berglin", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Gouras", "sequence": "additional", "affiliation": []}, {"given": "Y.", "family": "Sheng", "sequence": "additional", "affiliation": []}, {"given": "E. D.", "family": "Kopp", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Retina"], "language": "en", "link": [{"URL": "http://journals.lww.com/retinajournal/Fulltext/10.1097/00006982-199919050-00036", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 11, 29]], "date-time": "2018-11-29T13:23:20Z", "timestamp": 1543497800000}, "score": 40.913895, "subtitle": ["Observations in Disciform Lesions and Dry RPE Atrophy"], "issued": {"date-parts": [[1999]]}, "references-count": 0, "journal-issue": {"issue": "5"}, "URL": "http://dx.doi.org/10.1097/00006982-199919050-00036", "ISSN": ["0275-004X"], "issn-type": [{"value": "0275-004X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T17:30:48Z", "timestamp": 1574530248611}, "publisher-location": "New York, NY", "reference-count": 121, "publisher": "Springer New York", "isbn-type": [{"value": "9781461401247", "type": "print"}, {"value": "9781461401254", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2011]]}, "DOI": "10.1007/978-1-4614-0125-4_9", "type": "book-chapter", "created": {"date-parts": [[2011, 7, 27]], "date-time": "2011-07-27T19:06:57Z", "timestamp": 1311793617000}, "page": "135-153", "source": "Crossref", "is-referenced-by-count": 1, "title": ["The Future of Neovascular Age-Related Macular Degeneration"], "prefix": "10.1007", "author": [{"given": "Chirag P.", "family": "Shah", "sequence": "first", "affiliation": []}, {"given": "Jeffrey S.", "family": "Heier", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2011, 7, 1]]}, "reference": [{"issue": "4", "key": "9_CR1_9", "doi-asserted-by": "publisher", "first-page": "581", "DOI": "10.1210/er.2003-0027", "volume": "25", "author": "N Ferrara", "year": "2004", "unstructured": "Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004;25(4):581\u2013611.", "journal-title": "Endocr Rev"}, {"issue": "8", "key": "9_CR2_9", "doi-asserted-by": "publisher", "first-page": "859", "DOI": "10.1097/01.iae.0000242842.14624.e7", "volume": "26", "author": "N Ferrara", "year": "2006", "unstructured": "Ferrara N, Damico L, Shams N, et al. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina. 2006;26(8):859\u201370.", "journal-title": "Retina"}, {"issue": "14", "key": "9_CR3_9", "doi-asserted-by": "publisher", "first-page": "1419", "DOI": "10.1056/NEJMoa054481", "volume": "355", "author": "PJ Rosenfeld", "year": "2006", "unstructured": "Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419\u201331.", "journal-title": "N Engl J Med"}, {"issue": "14", "key": "9_CR4_9", "doi-asserted-by": "publisher", "first-page": "1432", "DOI": "10.1056/NEJMoa062655", "volume": "355", "author": "DM Brown", "year": "2006", "unstructured": "Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1432\u201344.", "journal-title": "N Engl J Med"}, {"issue": "1", "key": "9_CR5_9", "doi-asserted-by": "publisher", "first-page": "57", "DOI": "10.1016/j.ophtha.2008.10.018", "volume": "116", "author": "DM Brown", "year": "2009", "unstructured": "Brown DM, Michels M, Kaiser PK, et al. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology. 2009;116(1):57\u201365.e5.", "journal-title": "Ophthalmology"}, {"key": "9_CR6_9", "unstructured": "Comparison of age-related macular degeneration treatments trials: lucentis-avastin trial [ClinicalTrials.gov identifier: NCT00593450]. ClinicalTrials.gov online. http://www.clinicaltrials.gov/ct2/show/NCT00593450 . Accessed 16 Dec 2009."}, {"issue": "7", "key": "9_CR7_9", "doi-asserted-by": "publisher", "first-page": "3186", "DOI": "10.1167/iovs.02-1092", "volume": "44", "author": "JM Rakic", "year": "2003", "unstructured": "Rakic JM, Lambert V, Devy L, et al. Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2003;44(7):3186\u201393.", "journal-title": "Invest Ophthalmol Vis Sci"}, {"issue": "9", "key": "9_CR8_9", "doi-asserted-by": "publisher", "first-page": "1522.e1", "DOI": "10.1016/j.ophtha.2006.05.055", "volume": "113", "author": "QD Nguyen", "year": "2006", "unstructured": "Nguyen QD, Shah SM, Hafiz G, et al. A phase I trial of an IV-administered vascular endothelial growth factor trap for treatment in patients with choroidal neovascularization due to age-related macular degeneration. Ophthalmology. 2006;113(9):1522.e1\u201314.", "journal-title": "Ophthalmology"}, {"issue": "11", "key": "9_CR9_9", "doi-asserted-by": "publisher", "first-page": "2141", "DOI": "10.1016/j.ophtha.2009.04.030", "volume": "116", "author": "QD Nguyen", "year": "2009", "unstructured": "Nguyen QD, Shah SM, Browning DJ, et al. A phase I study of intravitreal vascular endothelial growth factor trap-eye in patients with neovascular age-related macular degeneration. Ophthalmology. 2009;116(11):2141\u20138.e1.", "journal-title": "Ophthalmology"}, {"key": "9_CR10_9", "unstructured": "Bayer HealthCare and Regeneron Announce VEGF trap-eye achieved durable improvement in vision over 52 weeks in a phase 2. http://www.medicalnewstoday.com/articles/119267.php . Accessed 4 Dec 2009."}, {"key": "9_CR11_9", "unstructured": "Vascular Endothelial Growth Factor (VEGF) trap-eye: investigation of efficacy and safety in wet age-related macular degeneration (AMD) (VIEW 1). ClinicalTrials.gov identifier: NCT00509795. ClinicalTrials.gov online. http://www.clinicaltrials.gov/ct2/show/NCT00509795 . Accessed 4 Dec 2009."}, {"key": "9_CR12_9", "unstructured": "Vascular Endothelial Growth Factor (VEGF) trap-eye: investigation of efficacy and safety in wet age-related macular degeneration (AMD) (VIEW 2). ClinicalTrials.gov identifier: NCT00637377. ClinicalTrials.gov online. http://www.clinicaltrials.gov/ct2/show/NCT00637377 . Accessed 4 Dec 2009."}, {"issue": "6 Suppl", "key": "9_CR13_9", "doi-asserted-by": "publisher", "first-page": "S49", "DOI": "10.1097/IAE.0b013e3181ad2341", "volume": "29", "author": "L Singerman", "year": "2009", "unstructured": "Singerman L. Combination therapy using the small interfering RNA bevasiranib. Retina. 2009;29(6 Suppl):S49\u201350.", "journal-title": "Retina"}, {"key": "9_CR14_9", "unstructured": "Singerman LJ. VEGF small interfering (si) RNA, for treatment of wet age-related macular degeneration (AMD). Presented at American Society of Retina Specialists, Cannes, 2006."}, {"issue": "2", "key": "9_CR15_9", "first-page": "377", "volume": "2", "author": "MV Emerson", "year": "2008", "unstructured": "Emerson MV, Lauer AK. Current and emerging therapies for the treatment of age-related macular degeneration. Clin Ophthalmol. 2008;2(2):377\u201388.", "journal-title": "Clin Ophthalmol"}, {"key": "9_CR16_9", "unstructured": "Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (COBALT). ClinicalTrials.gov identifier: NCT00499590. ClinicalTrials.gov online. http://www.clinicaltrials.gov/ct2/show/NCT00499590 . Accessed 5 Dec 2009."}, {"key": "9_CR17_9", "unstructured": "Bevasiranib, an siRNA targeting Vascular Endothelial Growth Factor (VEGF) for the treatment of age-related macular degeneration (AMD), is the most advanced siRNA at OPKO and the first siRNA in the industry to enter a Phase III clinical trial. OPKO\u2019s website. http://www.opko.com/research/?doc=ophthalmics . Accessed 5 Dec 2009."}, {"key": "9_CR18_9", "unstructured": "Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (CARBON). ClinicalTrials.gov identifier: NCT00557791. ClinicalTrials.gov online. http://www.clinicaltrials.gov/ct2/show/NCT00557791 . Accessed 5 Dec 2009."}, {"issue": "6", "key": "9_CR19_9", "doi-asserted-by": "publisher", "first-page": "669", "DOI": "10.1038/nm0603-669", "volume": "9", "author": "N Ferrara", "year": "2003", "unstructured": "Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9(6):669\u201376.", "journal-title": "Nat Med"}, {"issue": "29", "key": "9_CR20_9", "doi-asserted-by": "publisher", "first-page": "26969", "DOI": "10.1074/jbc.M103213200", "volume": "276", "author": "H Zeng", "year": "2001", "unstructured": "Zeng H, Dvorak HF, Mukhopadhyay D. Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) peceptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways. J Biol Chem. 2001;276(29):26969\u201379.", "journal-title": "J Biol Chem"}, {"issue": "3", "key": "9_CR21_9", "doi-asserted-by": "publisher", "first-page": "543", "DOI": "10.1083/jcb.153.3.543", "volume": "153", "author": "M Hellstrom", "year": "2001", "unstructured": "Hellstrom M, Gerhardt H, Kalen M, et al. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol. 2001;153(3):543\u201353.", "journal-title": "J Cell Biol"}, {"key": "9_CR22_9", "doi-asserted-by": "publisher", "first-page": "103", "DOI": "10.1007/978-3-540-78281-0_7", "volume": "180", "author": "C Hellberg", "year": "2010", "unstructured": "Hellberg C, Ostman A, Heldin CH. PDGF and vessel maturation. Recent Results Cancer Res. 2010;180:103\u201314.", "journal-title": "Recent Results Cancer Res"}, {"issue": "4", "key": "9_CR23_9", "doi-asserted-by": "publisher", "first-page": "660", "DOI": "10.1016/j.ajo.2006.05.061", "volume": "142", "author": "PK Kaiser", "year": "2006", "unstructured": "Kaiser PK. Antivascular endothelial growth factor agents and their development: therapeutic implications in ocular diseases. Am J Ophthalmol. 2006;142(4):660\u20138.", "journal-title": "Am J Ophthalmol"}, {"key": "9_CR24_9", "unstructured": "Safety and efficacy of oral PTK787 in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration (AMD) (ADVANCE). ClinicalTrials.gov identifier: NCT00138632. ClinicalTrials.gov online. http://clinicaltrials.gov/ct2/show/NCT00138632 . Accessed 20 Nov 2009."}, {"issue": "1", "key": "9_CR25_9", "doi-asserted-by": "publisher", "first-page": "29", "DOI": "10.1002/jcp.21426", "volume": "216", "author": "J Doukas", "year": "2008", "unstructured": "Doukas J, Mahesh S, Umeda N, et al. Topical administration of a multi-targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema. J Cell Physiol. 2008;216(1):29\u201337.", "journal-title": "J Cell Physiol"}, {"key": "9_CR26_9", "unstructured": "Roberts D. Antiangiogenic drugs are stopping neovascularization in wet macular degeneration. http://www.mdsupport.org/library/anti-angio.html . Accessed 6 Dec 2009."}, {"key": "9_CR27_9", "unstructured": "A phase 1 safety study of TG100801 eye drops in healthy volunteers. http://www.clinicaltrials.gov/ct2/show/NCT00414999 . Accessed 6 Dec 2009."}, {"key": "9_CR28_9", "unstructured": "Open-label, pilot study of TG100801 in patients with choroidal neovascularization due to AMD. ClinicalTrials.gov identifier: NCT00509548. ClinicalTrials.gov online. http://clinicaltrials.gov/ct2/show/NCT00509548 . Accessed 20 Nov 2009."}, {"issue": "2", "key": "9_CR29_9", "doi-asserted-by": "publisher", "first-page": "115", "DOI": "10.1007/s11912-007-0007-2", "volume": "9", "author": "G Sonpavde", "year": "2007", "unstructured": "Sonpavde G, Hutson TE. Pazopanib: a novel multitargeted tyrosine kinase inhibitor. Curr Oncol Rep. 2007;9(2):115\u20139.", "journal-title": "Curr Oncol Rep"}, {"key": "9_CR30_9", "unstructured": "A study to evaluate the pharmacodynamics, safety, and pharmacokinetics of pazopanib drops in adult subjects with neovascular AMD. ClinicalTrials.gov identifier: NCT00612456. http://www.clinicaltrials.gov/ct2/show/NCT00612456 . Accessed 6 Dec 2009."}, {"key": "9_CR31_9", "unstructured": "An extension to study MD7108240. ClinicalTrials.gov identifier: NCT00733304. http://www.clinicaltrials.gov/ct2/show/NCT00733304 . Accessed 6 Dec 2009."}, {"issue": "3", "key": "9_CR32_9", "doi-asserted-by": "publisher", "first-page": "225", "DOI": "10.1038/sj.gt.3302641", "volume": "13", "author": "J Shen", "year": "2006", "unstructured": "Shen J, Samul R, Silva RL, et al. Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1. Gene Ther. 2006;13(3):225\u201334.", "journal-title": "Gene Ther"}, {"key": "9_CR33_9", "unstructured": "Sirna therapeutics reports final results from phase 1 study in its RNAi-based therapeutic for age-related macular degeneration. http://www.medicalnewstoday.com/articles/49334.php . Accessed 6 December 2009."}, {"key": "9_CR34_9", "unstructured": "Allergan drops development of siRNA Rx for AMD on poor phase II data. http://www.genomeweb.com/rnai/allergan-drops-development-sirna-rx-amd-poor-phase-ii-data . Accessed 2 Jan 2010."}, {"key": "9_CR35_9", "unstructured": "A study using intravitreal injections of a small interfering RNA in patients with age-related macular degeneration. ClinicalTrials.gov identifier: NCT00395057. ClinicalTrials.gov online. http://www.clinicaltrials.gov/ct2/show/NCT00395057 . Accessed 6 Dec 2009."}, {"issue": "1", "key": "9_CR36_9", "doi-asserted-by": "crossref", "first-page": "51", "DOI": "10.1172/JCI200110128", "volume": "108", "author": "JM Wigginton", "year": "2001", "unstructured": "Wigginton JM, Gruys E, Geiselhart L, et al. IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy. J Clin Invest. 2001;108(1):51\u201362.", "journal-title": "J Clin Invest"}, {"issue": "10", "key": "9_CR37_9", "doi-asserted-by": "publisher", "first-page": "4795", "DOI": "10.1167/iovs.07-0425", "volume": "48", "author": "H Mochimaru", "year": "2007", "unstructured": "Mochimaru H, Nagai N, Hasegawa G, et al. Suppression of choroidal neovascularization by dendritic cell vaccination targeting VEGFR2. Invest Ophthalmol Vis Sci. 2007;48(10):4795\u2013801.", "journal-title": "Invest Ophthalmol Vis Sci"}, {"key": "9_CR38_9", "unstructured": "Anti-VEGFR vaccine therapy in treating patients with neovascular maculopathy. ClinicalTrials.gov identifier: NCT00791570. ClinicalTrials.gov online. http://www.clinicaltrials.gov/ct2/show/NCT00791570 . Accessed 6 Dec 2009."}, {"issue": "6", "key": "9_CR39_9", "doi-asserted-by": "publisher", "first-page": "401", "DOI": "10.1159/000228926", "volume": "223", "author": "Z Ni", "year": "2009", "unstructured": "Ni Z, Hui P. Emerging pharmacologic therapies for wet age-related macular degeneration. Ophthalmologica. 2009;223(6):401\u201310.", "journal-title": "Ophthalmologica"}, {"key": "9_CR40_9", "unstructured": "A phase 1, safety, tolerability and pharmacokinetic profile of intravitreous injections of E10030 (Anti-PDGF Pegylated Aptamer) in subjects with neovascular age-related macular degeneration. ClinicalTrials.gov identifier: NCT00569140. ClinicalTrials.gov online. http://www.clinicaltrials.gov/ct2/show/NCT00569140 . Accessed 27 Dec 2009."}, {"key": "9_CR41_9", "unstructured": "Kuppermann B. Combined inhibition of platelet-\u00adderived growth factor (PDGF) and VEGF for treatment of neovascular AMD \u2013 Results of a phase 1 study. Retina Congress, NYC, NY 2009."}, {"key": "9_CR42_9", "unstructured": "Study of Anti-PDGF and Anti-VEGF therapy shows significant neovascular regression and enhanced visual outcome. http://www.medicalnewstoday.com/articles/148727.php . Accessed 27 Dec 2009."}, {"issue": "12", "key": "9_CR43_9", "doi-asserted-by": "crossref", "first-page": "2239", "DOI": "10.1016/S0161-6420(99)90522-5", "volume": "106", "author": "The Radiation Therapy for Age-related Macular Degeneration (RAD) Study Group", "year": "1999", "unstructured": "The Radiation Therapy for Age-related Macular Degeneration (RAD) Study Group. A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD Study). Ophthalmology. 1999;106(12):2239\u201347.", "journal-title": "Ophthalmology"}, {"issue": "2", "key": "9_CR44_9", "first-page": "171", "volume": "119", "author": "DM Marcus", "year": "2001", "unstructured": "Marcus DM, Sheils W, Johnson MH, et al. External beam irradiation of subfoveal choroidal neovascularization complicating age-related macular degeneration: one-year results of a prospective, double-masked, randomized clinical trial. Arch Ophthalmol. 2001;119(2):171\u201380.", "journal-title": "Arch Ophthalmol"}, {"issue": "8", "key": "9_CR45_9", "doi-asserted-by": "crossref", "first-page": "1029", "DOI": "10.1001/archopht.120.8.1029", "volume": "120", "author": "PM Hart", "year": "2002", "unstructured": "Hart PM, Chakravarthy U, Mackenzie G, et al. Visual outcomes in the subfoveal radiotherapy study: a randomized controlled trial of teletherapy for age-related macular degeneration. Arch Ophthalmol. 2002;120(8):1029\u201338.", "journal-title": "Arch Ophthalmol"}, {"issue": "11", "key": "9_CR46_9", "doi-asserted-by": "publisher", "first-page": "2012", "DOI": "10.1016/j.ophtha.2006.05.036", "volume": "113", "author": "HJ Zambarakji", "year": "2006", "unstructured": "Zambarakji HJ, Lane AM, Ezra E, et al. Proton beam irradiation for neovascular age-related macular degeneration. Ophthalmology. 2006;113(11):2012\u20139.", "journal-title": "Ophthalmology"}, {"issue": "1", "key": "9_CR47_9", "doi-asserted-by": "publisher", "first-page": "147", "DOI": "10.1016/0360-3016(88)90359-8", "volume": "15", "author": "L Krishnan", "year": "1988", "unstructured": "Krishnan L, Krishnan EC, Jewell WR. Immediate effect of irradiation on microvasculature. Int J Radiat Oncol Biol Phys. 1988;15(1):147\u201350.", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"issue": "4", "key": "9_CR48_9", "doi-asserted-by": "publisher", "first-page": "337", "DOI": "10.3109/02713688908996381", "volume": "8", "author": "U Chakravarthy", "year": "1989", "unstructured": "Chakravarthy U, Gardiner TA, Archer DB, Maguire CJ. A light microscopic and autoradiographic study of non-irradiated and irradiated ocular wounds. Curr Eye Res. 1989;8(4):337\u201348.", "journal-title": "Curr Eye Res"}, {"issue": "18", "key": "9_CR49_9", "doi-asserted-by": "publisher", "first-page": "3020", "DOI": "10.1200/JCO.2008.21.1771", "volume": "27", "author": "CG Willett", "year": "2009", "unstructured": "Willett CG, Duda DG, di Tomaso E, et al. Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study. J Clin Oncol. 2009;27(18):3020\u20136.", "journal-title": "J Clin Oncol"}, {"issue": "5 Suppl 10", "key": "9_CR50_9", "doi-asserted-by": "publisher", "first-page": "S35", "DOI": "10.1053/j.seminoncol.2006.08.007", "volume": "33", "author": "CG Willett", "year": "2006", "unstructured": "Willett CG, Kozin SV, Duda DG, et al. Combined vascular endothelial growth factor-targeted therapy and radiotherapy for rectal cancer: theory and clinical practice. Semin Oncol. 2006;33(5 Suppl 10):S35\u201340.", "journal-title": "Semin Oncol"}, {"issue": "2", "key": "9_CR51_9", "doi-asserted-by": "publisher", "first-page": "157", "DOI": "10.1097/IAE.0b013e3181985915", "volume": "29", "author": "MP Avila", "year": "2009", "unstructured": "Avila MP, Farah ME, Santos A, et al. Twelve-month safety and visual acuity results from a feasibility study of intraocular, epiretinal radiation therapy for the treatment of subfoveal CNV secondary to AMD. Retina. 2009;29(2):157\u201369.", "journal-title": "Retina"}, {"key": "9_CR52_9", "unstructured": "Dugel P. Epimacular brachytherapy for the treatment of neovascular AMD: NVI-111 24 Month VA outcomes. Presented at retina congress 2009, New York City, 2009. http://www.neovistainc.com/docs/press/Final-24-Month-Review-of-NVI-111-Study.pdf . Accessed 7 Dec 2009."}, {"issue": "3", "key": "9_CR53_9", "doi-asserted-by": "publisher", "first-page": "305", "DOI": "10.1136/bjo.2008.145912", "volume": "93", "author": "MP Avila", "year": "2009", "unstructured": "Avila MP, Farah ME, Santos A, et al. Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration. Br J Ophthalmol. 2009;93(3):305\u20139.", "journal-title": "Br J Ophthalmol"}, {"key": "9_CR54_9", "unstructured": "A study of the NeoVista ophthalmic system for the treatment of subfoveal CNV associated with wet AMD in patients that require persistent anti-VEGF therapy (MERITAGE). ClinicalTrials.gov identifier: NCT00809419. ClinicalTrials.gov online. http://clinicaltrials.gov/ct2/show/NCT00809419 . Accessed 7 Dec 2009."}, {"key": "9_CR55_9", "unstructured": "A study to evaluate the Neovista ophthalmic system for the treatment of subfoveal CNV in patients with AMD that have failed primary anti-VEGF therapy (ROSE). ClinicalTrials.gov identifier: NCT00679445. ClinicalTrials.gov online. http://clinicaltrials.gov/ct2/show/NCT00679445 . Accessed 22 Dec 2009."}, {"key": "9_CR56_9", "unstructured": "Macular EpiRetinal Brachytherapy Versus Lucentis\u00ae Only Treatment (MERLOT). ClinicalTrials.gov identifier: NCT01006538. ClinicalTrials.gov online. http://clinicaltrials.gov/ct2/show/NCT01006538 . Accessed 22 Dec 2009."}, {"key": "9_CR57_9", "unstructured": "Kaiser P. Externally-applied stereotactic orthovoltage irradiation for age-related macular degeneration: case presentations from a phase I clinical trial. Retina Congress, NYC, NY, 2009.", "DOI": "10.1097/IAE.0b013e3181ad242f", "doi-asserted-by": "crossref"}, {"key": "9_CR58_9", "unstructured": "Safety & efficacy study of the IRay system in patients with choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD). ClinicalTrials.gov identifier: NCT01016873. ClinicalTrials.gov online. http://clinicaltrials.gov/ct2/show/NCT01016873 . Accessed 22 Dec 2009."}, {"issue": "1", "key": "9_CR59_9", "doi-asserted-by": "publisher", "first-page": "3", "DOI": "10.1080/09273940590909185", "volume": "13", "author": "A Kijlstra", "year": "2005", "unstructured": "Kijlstra A, La Heij E, Hendrikse F. Immunological factors in the pathogenesis and treatment of age-related macular degeneration. Ocul Immunol Inflamm. 2005;13(1):3\u201311.", "journal-title": "Ocul Immunol Inflamm"}, {"issue": "12", "key": "9_CR60_9", "doi-asserted-by": "publisher", "first-page": "5818", "DOI": "10.1167/iovs.09-3928", "volume": "50", "author": "R Reynolds", "year": "2009", "unstructured": "Reynolds R, Hartnett ME, Atkinson JP, et al. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest Ophthalmol Vis Sci. 2009;50(12):5818\u201327.", "journal-title": "Invest Ophthalmol Vis Sci"}, {"key": "9_CR61_9", "first-page": "119", "volume": "8", "author": "HE Grossniklaus", "year": "2002", "unstructured": "Grossniklaus HE, Ling JX, Wallace TM, et al. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol Vis. 2002;8:119\u201326.", "journal-title": "Mol Vis"}, {"issue": "7", "key": "9_CR62_9", "doi-asserted-by": "publisher", "first-page": "2328", "DOI": "10.1073/pnas.0408835103", "volume": "103", "author": "M Nozaki", "year": "2006", "unstructured": "Nozaki M, Raisler BJ, Sakurai E, et al. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci USA. 2006;103(7):2328\u201333.", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "9", "key": "9_CR63_9", "first-page": "1891", "volume": "40", "author": "H Oh", "year": "1999", "unstructured": "Oh H, Takagi H, Takagi C, et al. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 1999;40(9):1891\u20138.", "journal-title": "Invest Ophthalmol Vis Sci"}, {"key": "9_CR64_9", "unstructured": "Potentia pharmaceuticals\u2019 POT-4 drug candidate for age-related macular degeneration successfully completes phase I clinical trial. http://www.medicalnewstoday.com/articles/148725.php . Accessed 24 Dec 2009."}, {"key": "9_CR65_9", "unstructured": "Safety of intravitreal POT-4 therapy for patients with neovascular age-related macular degeneration (AMD) (ASaP). ClinicalTrials.gov identifier: NCT00473928. http://www.clinicaltrials.gov/ct2/show/NCT00473928 . Accessed 24 Dec 2009."}, {"key": "9_CR66_9", "unstructured": "ARC1905 (ANTI-C5 APTAMER) given either in combination therapy with Lucentis\u00ae 0.5 mg/eye in subjects with neovascular age-related macular degeneration. ClinicalTrials.gov identifier: NCT00709527. ClinicalTrials.gov online. http://www.clinicaltrials.gov/ct2/show/NCT00709527 . Accessed 25 Dec 2009."}, {"key": "9_CR67_9", "unstructured": "A Study of ARC1905 (Anti-C5 Aptamer) in subjects with dry age-related macular degeneration. ClinicalTrials.gov identifier: NCT00950638. ClinicalTrials.gov online. http://www.clinicaltrials.gov/ct2/show/NCT00950638 . Accessed 25 Dec 2009."}, {"issue": "9", "key": "9_CR68_9", "doi-asserted-by": "publisher", "first-page": "1221", "DOI": "10.1001/archopht.125.9.1221", "volume": "125", "author": "JL Olson", "year": "2007", "unstructured": "Olson JL, Courtney RJ, Mandava N. Intravitreal infliximab and choroidal neovascularization in an animal model. Arch Ophthalmol. 2007;125(9):1221\u20134.", "journal-title": "Arch Ophthalmol"}, {"issue": "2", "key": "9_CR69_9", "doi-asserted-by": "publisher", "first-page": "273", "DOI": "10.1007/s00417-008-0967-4", "volume": "247", "author": "PG Theodossiadis", "year": "2009", "unstructured": "Theodossiadis PG, Liarakos VS, Sfikakis PP, et al. Intravitreal administration of the anti-TNF monoclonal antibody infliximab in the rabbit. Graefes Arch Clin Exp Ophthalmol. 2009;247(2):273\u201381.", "journal-title": "Graefes Arch Clin Exp Ophthalmol"}, {"issue": "5", "key": "9_CR70_9", "doi-asserted-by": "publisher", "first-page": "825", "DOI": "10.1016/j.ajo.2008.12.004", "volume": "147", "author": "PG Theodossiadis", "year": "2009", "unstructured": "Theodossiadis PG, Liarakos VS, Sfikakis PP, et al. Intravitreal administration of the anti-tumor necrosis factor agent infliximab for neovascular age-related macular degeneration. Am J Ophthalmol. 2009;147(5):825\u201330, 30.e1.", "journal-title": "Am J Ophthalmol"}, {"key": "9_CR71_9", "unstructured": "Intravitreal infliximab for diabetic macular edema (DME) and choroidal neovascularization (CNV) (ITVR). ClinicalTrials.gov identifier: NCT00695682. ClinicalTrials.gov online. http://www.clinicaltrials.gov/ct2/show/NCT00695682 . Accessed 24 Dec 2009."}, {"issue": "16", "key": "9_CR72_9", "doi-asserted-by": "publisher", "first-page": "1926", "DOI": "10.1101/gad.1212704", "volume": "18", "author": "N Hay", "year": "2004", "unstructured": "Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev. 2004;18(16):1926\u201345.", "journal-title": "Genes Dev"}, {"issue": "2", "key": "9_CR73_9", "doi-asserted-by": "publisher", "first-page": "128", "DOI": "10.1038/nm0202-128", "volume": "8", "author": "M Guba", "year": "2002", "unstructured": "Guba M, von Breitenbuch P, Steinbauer M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med. 2002;8(2):128\u201335.", "journal-title": "Nat Med"}, {"issue": "10", "key": "9_CR74_9", "doi-asserted-by": "publisher", "first-page": "2128", "DOI": "10.1007/s10620-008-0605-3", "volume": "54", "author": "W Wang", "year": "2009", "unstructured": "Wang W, Jia WD, Xu GL, et al. Antitumoral activity of rapamycin mediated through inhibition of HIF-1alpha and VEGF in hepatocellular carcinoma. Dig Dis Sci. 2009;54(10):2128\u201336.", "journal-title": "Dig Dis Sci"}, {"key": "9_CR75_9", "first-page": "964", "volume": "10", "author": "NS Dejneka", "year": "2004", "unstructured": "Dejneka NS, Kuroki AM, Fosnot J, et al. Systemic rapamycin inhibits retinal and choroidal neovascularization in mice. Mol Vis. 2004;10:964\u201372.", "journal-title": "Mol Vis"}, {"key": "9_CR76_9", "unstructured": "Phase 1/2 Study of an ocular sirolimus (Rapamycin) formulation in patients with age-related macular degeneration. ClinicalTrials.gov identifier: NCT00712491. ClinicalTrials.gov online. http://www.clinicaltrials.gov/ct2/show/NCT00712491 . Accessed 26 Dec 2009."}, {"key": "9_CR77_9", "unstructured": "MacuSight (TM) announces positive preliminary results from phase 1 study of Sirolimus in wet age-related macular degeneration. http://www.medicalnewstoday.com/articles/98491.php . Accessed 26 Dec 2009."}, {"key": "9_CR78_9", "unstructured": "Phase 2 study of an ocular sirolimus (Rapamycin) formulation in combination with Lucentis\u00ae in Patients with age-related macular degeneration (EMERALD). ClinicalTrials.gov identifier: NCT00766337. ClinicalTrials.gov online. http://www.clinicaltrials.gov/ct2/show/NCT00766337 . Accessed 26 Dec 2009."}, {"issue": "1", "key": "9_CR79_9", "doi-asserted-by": "publisher", "first-page": "25", "DOI": "10.2174/156652307779940252", "volume": "7", "author": "PA Campochiaro", "year": "2007", "unstructured": "Campochiaro PA. Gene therapy for ocular neovascularization. Curr Gene Ther. 2007;7(1):25\u201333.", "journal-title": "Curr Gene Ther"}, {"issue": "4", "key": "9_CR80_9", "doi-asserted-by": "publisher", "first-page": "1526", "DOI": "10.1073/pnas.90.4.1526", "volume": "90", "author": "FR Steele", "year": "1993", "unstructured": "Steele FR, Chader GJ, Johnson LV, Tombran-Tink J. Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc Natl Acad Sci USA. 1993;90(4):1526\u201330.", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "3", "key": "9_CR81_9", "first-page": "821", "volume": "43", "author": "EJ Duh", "year": "2002", "unstructured": "Duh EJ, Yang HS, Suzuma I, et al. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest Ophthalmol Vis Sci. 2002;43(3):821\u20139.", "journal-title": "Invest Ophthalmol Vis Sci"}, {"issue": "7", "key": "9_CR82_9", "first-page": "2428", "volume": "43", "author": "K Mori", "year": "2002", "unstructured": "Mori K, Gehlbach P, Ando A, et al. Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor. Invest Ophthalmol Vis Sci. 2002;43(7):2428\u201334.", "journal-title": "Invest Ophthalmol Vis Sci"}, {"issue": "8", "key": "9_CR83_9", "doi-asserted-by": "publisher", "first-page": "637", "DOI": "10.1038/sj.gt.3301931", "volume": "10", "author": "P Gehlbach", "year": "2003", "unstructured": "Gehlbach P, Demetriades AM, Yamamoto S, et al. Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization. Gene Ther. 2003;10(8):637\u201346.", "journal-title": "Gene Ther"}, {"issue": "2", "key": "9_CR84_9", "doi-asserted-by": "publisher", "first-page": "167", "DOI": "10.1089/hum.2006.17.167", "volume": "17", "author": "PA Campochiaro", "year": "2006", "unstructured": "Campochiaro PA, Nguyen QD, Shah SM, et al. Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial. Hum Gene Ther. 2006;17(2):167\u201376.", "journal-title": "Hum Gene Ther"}, {"key": "9_CR85_9", "unstructured": "Study of AdGVPEDF.11D in neovascular age-related macular degeneration (AMD). ClinicalTrials.gov identifier: NCT00109499. ClinicalTrials.gov online. http://www.clinicaltrials.gov/ct2/show/NCT00109499 . Accessed 26 Dec 2009."}, {"issue": "16", "key": "9_CR86_9", "first-page": "2029", "volume": "12", "author": "H Rasmussen", "year": "2001", "unstructured": "Rasmussen H, Chu KW, Campochiaro P, et al. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD). Hum Gene Ther. 2001;12(16):2029\u201332.", "journal-title": "Hum Gene Ther"}, {"issue": "1", "key": "9_CR87_9", "doi-asserted-by": "publisher", "first-page": "299", "DOI": "10.1167/iovs.05-0731", "volume": "47", "author": "MM Hamilton", "year": "2006", "unstructured": "Hamilton MM, Brough DE, McVey D, et al. Repeated administration of adenovector in the eye results in efficient gene delivery. Invest Ophthalmol Vis Sci. 2006;47(1):299\u2013305.", "journal-title": "Invest Ophthalmol Vis Sci"}, {"issue": "1", "key": "9_CR88_9", "doi-asserted-by": "publisher", "first-page": "10", "DOI": "10.1038/gt.2008.115", "volume": "16", "author": "P Pechan", "year": "2009", "unstructured": "Pechan P, Rubin H, Lukason M, et al. Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization. Gene Ther. 2009;16(1):10\u20136.", "journal-title": "Gene Ther"}, {"key": "9_CR89_9", "unstructured": "Safety and tolerability study of AAV2-sFLT01 in patients with neovascular age-related macular degeneration (AMD). ClinicalTrials.gov identifier: NCT01024998. ClinicalTrials.gov online. http://www.clinicaltrials.gov/ct2/show/NCT01024998 . Accessed 26 Dec 2009."}, {"issue": "4", "key": "9_CR90_9", "doi-asserted-by": "publisher", "first-page": "1705", "DOI": "10.1167/iovs.07-0089", "volume": "49", "author": "K Kiuchi", "year": "2008", "unstructured": "Kiuchi K, Matsuoka M, Wu JC, et al. Mecamylamine suppresses Basal and nicotine-stimulated choroidal neovascularization. Invest Ophthalmol Vis Sci. 2008;49(4):1705\u201311.", "journal-title": "Invest Ophthalmol Vis Sci"}, {"key": "9_CR91_9", "unstructured": "Safety and efficacy of ATG003 in patients with wet age-related macular degeneration (AMD). ClinicalTrials.gov identifier: NCT00414206. ClinicalTrials.gov online. http://www.clinicaltrials.gov/ct2/show/NCT00414206 . Accessed 26 Dec 2009."}, {"key": "9_CR92_9", "unstructured": "Safety and efficacy of ATG003 in patients with AMD receiving anti-VEGF. ClinicalTrials.gov identifier: NCT00607750. ClinicalTrials.gov online. http://www.clinicaltrials.gov/ct2/show/NCT00607750 . Accessed 26 Dec 2009."}, {"issue": "3", "key": "9_CR93_9", "first-page": "381", "volume": "19", "author": "B Connolly", "year": "2006", "unstructured": "Connolly B, Desai A, Garcia CA, et al. Squalamine lactate for exudative age-related macular degeneration. Ophthalmol Clin North Am. 2006;19(3):381\u201391, vi.", "journal-title": "Ophthalmol Clin North Am"}, {"issue": "6", "key": "9_CR94_9", "doi-asserted-by": "publisher", "first-page": "808", "DOI": "10.1097/00006982-200312000-00011", "volume": "23", "author": "TA Ciulla", "year": "2003", "unstructured": "Ciulla TA, Criswell MH, Danis RP, et al. Squalamine lactate reduces choroidal neovascularization in a laser-injury model in the rat. Retina. 2003;23(6):808\u201314.", "journal-title": "Retina"}, {"key": "9_CR95_9", "unstructured": "A safety and efficacy study of MSI-1256F (Squalamine Lactate) to treat \u201cwet\u201d age-related macular degeneration. ClinicalTrials.gov identifier: NCT00593450. ClinicalTrials.gov online. http://www.clinicaltrials.gov/ct2/show/NCT00089830 . Accessed 26 Dec 2009."}, {"key": "9_CR96_9", "unstructured": "A study of MSI-1256 F (Squalamine Lactate) to treat \u201cwet\u201d age-related macular degeneration. ClinicalTrials.gov identifier: NCT00333476. ClinicalTrials.gov online. http://www.clinicaltrials.gov/ct2/show/NCT00333476 . Accessed 26 Dec 2009."}, {"key": "9_CR97_9", "unstructured": "MSI-1256 F (Squalamine Lactate) in combination with verteporfin in patients with \u201cwet\u201d age-related macular degeneration (AMD). ClinicalTrials.gov identifier: NCT00094120. ClinicalTrials.gov online. http://www.clinicaltrials.gov/ct2/show/NCT00094120 . Accessed 26 Dec 2009."}, {"key": "9_CR98_9", "unstructured": "A Safety and Efficacy Study of Squalamine Lactate for Injection (MSI-1256F) for \u201cwet\u201d age-related macular degeneration. ClinicalTrials.gov identifier: NCT00139282. ClinicalTrials.gov online. http://www.clinicaltrials.gov/ct2/show/NCT00139282 . Accessed 26 Dec 2009."}, {"issue": "17", "key": "9_CR99_9", "first-page": "6413", "volume": "61", "author": "GM Tozer", "year": "2001", "unstructured": "Tozer GM, Prise VE, Wilson J, et al. Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability. Cancer Res. 2001;61(17):6413\u201322.", "journal-title": "Cancer Res"}, {"issue": "11", "key": "9_CR100_9", "doi-asserted-by": "publisher", "first-page": "2992", "DOI": "10.1172/JCI24586", "volume": "115", "author": "L Vincent", "year": "2005", "unstructured": "Vincent L, Kermani P, Young LM, et al. Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling. J Clin Invest. 2005;115(11):2992\u20133006.", "journal-title": "J Clin Invest"}, {"issue": "2", "key": "9_CR101_9", "doi-asserted-by": "publisher", "first-page": "132", "DOI": "10.1089/jop.2006.0103", "volume": "23", "author": "PF Kador", "year": "2007", "unstructured": "Kador PF, Blessing K, Randazzo J, et al. Evaluation of the vascular targeting agent combretastatin a-4 prodrug on retinal neovascularization in the galactose-fed dog. J Ocul Pharmacol Ther. 2007;23(2):132\u201342.", "journal-title": "J Ocul Pharmacol Ther"}, {"key": "9_CR102_9", "unstructured": "OXiGENE announces interim results of wet age-related macular degeneration trial of Combretastatin A4 prodrug. http://www.thefreelibrary.com/OXiGENE+Announces+Interim+Results+of+Wet+Age-Related+Macular...-a0116742838 . Accessed 9 Jan 2010."}, {"key": "9_CR103_9", "unstructured": "Wong TP BD, Benz MS. Phase II clinical trial of intravenous combretastatin a4 phosphate in patients with subfoveal choroidal neovascular membranes (CNV) in pathologic myopia. Presented at ARVO, Ft. Lauderdale, 2007."}, {"key": "9_CR104_9", "unstructured": "OXiGENE announces positive results from its phase II CA4P clinical trial in myopic macular degeneration (MMD-213). http://www.thefreelibrary.com/OXiGENE+Announces+Positive+Results+from+its+Phase+II+CA4P+Clinical+...-a0159340756 . Accessed 9 Jan 2010."}, {"key": "9_CR105_9", "unstructured": "OXiGENE reports positive preclinical ocular penetration data with topical formulation of ZYBRESTAT(TM) for Ophthalmology. http://www.highbeam.com/doc/1G1-172903545.html . Accessed 27 Dec 2009."}, {"issue": "4", "key": "9_CR106_9", "first-page": "273", "volume": "5", "author": "V Ramakrishnan", "year": "2006", "unstructured": "Ramakrishnan V, Bhaskar V, Law DA, et al. Preclinical evaluation of an anti-alpha5beta1 integrin antibody as a novel anti-angiogenic agent. J Exp Ther Oncol. 2006;5(4):273\u201386.", "journal-title": "J Exp Ther Oncol"}, {"issue": "9", "key": "9_CR107_9", "doi-asserted-by": "publisher", "first-page": "801", "DOI": "10.1080/02713680701553052", "volume": "32", "author": "AK Maier", "year": "2007", "unstructured": "Maier AK, Kociok N, Zahn G, et al. Modulation of hypoxia-induced neovascularization by JSM6427, an integrin alpha5beta1 inhibiting molecule. Curr Eye Res. 2007;32(9):801\u201312.", "journal-title": "Curr Eye Res"}, {"issue": "10", "key": "9_CR108_9", "doi-asserted-by": "publisher", "first-page": "1329", "DOI": "10.1001/archophthalmol.2009.265", "volume": "127", "author": "G Zahn", "year": "2009", "unstructured": "Zahn G, Vossmeyer D, Stragies R, et al. Preclinical evaluation of the novel small-molecule integrin alpha5beta1 inhibitor JSM6427 in monkey and rabbit models of choroidal neovascularization. Arch Ophthalmol. 2009;127(10):1329\u201335.", "journal-title": "Arch Ophthalmol"}, {"issue": "12", "key": "9_CR109_9", "doi-asserted-by": "publisher", "first-page": "5988", "DOI": "10.1167/iovs.09-3591", "volume": "50", "author": "R Li", "year": "2009", "unstructured": "Li R, Maminishkis A, Zahn G, et al. Integrin alpha5beta1 mediates attachment, migration, and proliferation in human retinal pigment epithelium: relevance for proliferative retinal disease. Invest Ophthalmol Vis Sci. 2009;50(12):5988\u201396.", "journal-title": "Invest Ophthalmol Vis Sci"}, {"key": "9_CR110_9", "unstructured": "A phase 1 safety study of single and repeated doses of JSM6427 (intravitreal injection) to treat AMD. ClinicalTrials.gov identifier: NCT00536016. ClinicalTrials.gov online. http://www.clinicaltrials.gov/ct2/show/NCT00536016 . Accessed 26 Dec 2009."}, {"key": "9_CR111_9", "unstructured": "A phase 1 ascending and parallel group trial to establish the safety, tolerability and pharmacokinetics profile of volociximab (alpha 5 beta 1 integrin antagonist) in subjects with neovascular age-related macular degeneration. ClinicalTrials.gov identifier: NCT00782093. ClinicalTrials.gov online. http://www.clinicaltrials.gov/ct2/show/NCT00782093 . Accessed 27 Dec 2009."}, {"key": "9_CR112_9", "unstructured": "Mones J. combined inhibition of \u03b15\u03b21 integrin and vascular endothelial growth factor for neovascular age-related macular degeneration \u2013 phase 1 study. Retina Congress, NYC, NY, 2009."}, {"issue": "10", "key": "9_CR113_9", "first-page": "3292", "volume": "43", "author": "W Tao", "year": "2002", "unstructured": "Tao W, Wen R, Goddard MB, et al. Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2002;43(10):3292\u20138.", "journal-title": "Invest Ophthalmol Vis Sci"}, {"issue": "5", "key": "9_CR114_9", "first-page": "506", "volume": "10", "author": "DF Emerich", "year": "2008", "unstructured": "Emerich DF, Thanos CG. NT-501: an ophthalmic implant of polymer-encapsulated ciliary neurotrophic factor-producing cells. Curr Opin Mol Ther. 2008;10(5):506\u201315.", "journal-title": "Curr Opin Mol Ther"}, {"issue": "52", "key": "9_CR115_9", "doi-asserted-by": "publisher", "first-page": "13523", "DOI": "10.1523/JNEUROSCI.4021-06.2006", "volume": "26", "author": "R Wen", "year": "2006", "unstructured": "Wen R, Song Y, Kjellstrom S, et al. Regulation of rod phototransduction machinery by ciliary neurotrophic factor. J Neurosci. 2006;26(52):13523\u201330.", "journal-title": "J Neurosci"}, {"key": "9_CR116_9", "unstructured": "A study of an encapsulated cell technology (ECT) implant for patients with atrophic macular degeneration. ClinicalTrials.gov identifier: NCT00447954. ClinicalTrials.gov online. http://www.clinicaltrials.gov/ct2/show/NCT00447954 . Accessed 16 Dec 2009."}, {"issue": "7", "key": "9_CR117_9", "first-page": "52", "volume": "4", "author": "G Jaffe", "year": "2009", "unstructured": "Jaffe G. CNTF-secreting implant for dry AMD. Retina Today. 2009;4(7):52\u20133.", "journal-title": "Retina Today"}, {"issue": "1", "key": "9_CR118_9", "doi-asserted-by": "publisher", "first-page": "192", "DOI": "10.1002/jcp.21588", "volume": "218", "author": "B Xie", "year": "2009", "unstructured": "Xie B, Shen J, Dong A, et al. Blockade of sphingosine-1-phosphate reduces macrophage influx and retinal and choroidal neovascularization. J Cell Physiol. 2009;218(1):192\u20138.", "journal-title": "J Cell Physiol"}, {"issue": "3", "key": "9_CR119_9", "doi-asserted-by": "publisher", "first-page": "367", "DOI": "10.1016/j.exer.2008.07.012", "volume": "88", "author": "S Caballero", "year": "2009", "unstructured": "Caballero S, Swaney J, Moreno K, et al. Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization. Exp Eye Res. 2009;88(3):367\u201377.", "journal-title": "Exp Eye Res"}, {"key": "9_CR120_9", "unstructured": "Safety study of iSONEP (Sonepcizumab/LT1009) to treat neovascular age-related macular degeneration. ClinicalTrials.gov identifier: NCT00767949. ClinicalTrials.gov online. http://www.clinicaltrials.gov/ct2/show/NCT00767949 . Accessed 21 Feb 2010."}, {"key": "9_CR121_9", "unstructured": "Lpath\u2019s ISONEP is well tolerated at all dose levels in a phase 1 trial in wet-AMD patients. http://www.medicalnewstoday.com/articles/166897.php . Accessed 21 Feb 2010."}], "container-title": ["Age-related Macular Degeneration Diagnosis and Treatment"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-4614-0125-4_9", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 13]], "date-time": "2019-06-13T13:25:22Z", "timestamp": 1560432322000}, "score": 40.751198, "issued": {"date-parts": [[2011]]}, "ISBN": ["9781461401247", "9781461401254"], "references-count": 121, "URL": "http://dx.doi.org/10.1007/978-1-4614-0125-4_9", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T08:54:43Z", "timestamp": 1574412883356}, "reference-count": 61, "publisher": "S. Karger AG", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Ophthalmologica"], "published-print": {"date-parts": [[2011]]}, "DOI": "10.1159/000330420", "type": "journal-article", "created": {"date-parts": [[2011, 10, 27]], "date-time": "2011-10-27T07:31:05Z", "timestamp": 1319700665000}, "page": "182-190", "source": "Crossref", "is-referenced-by-count": 21, "title": ["Imaging Geographic Atrophy in Age-Related Macular Degeneration"], "prefix": "10.1159", "volume": "226", "author": [{"given": "Arno P.", "family": "G\u00f6bel", "sequence": "first", "affiliation": []}, {"given": "Monika", "family": "Fleckenstein", "sequence": "additional", "affiliation": []}, {"given": "Steffen", "family": "Schmitz-Valckenberg", "sequence": "additional", "affiliation": []}, {"given": "Christian K.", "family": "Brinkmann", "sequence": "additional", "affiliation": []}, {"given": "Frank G.", "family": "Holz", "sequence": "additional", "affiliation": []}], "member": "127", "reference": [{"key": "sref_1", "author": "Klein R", "volume": "114", "first-page": "253", "year": "2007", "journal-title": "Ophthalmology", "DOI": "10.1016/j.ophtha.2006.10.040", "doi-asserted-by": "crossref"}, {"key": "sref_2", "author": "Augood CA", "volume": "124", "first-page": "529", "year": "2006", "journal-title": "Arch Ophthalmol", "DOI": "10.1001/archopht.124.4.529", "doi-asserted-by": "crossref"}, {"key": "sref_3", "author": "Sarks SH", "volume": "60", "first-page": "324", "year": "1976", "journal-title": "Br J Ophthalmol", "DOI": "10.1136/bjo.60.5.324", "doi-asserted-by": "crossref"}, {"key": "sref_4", "author": "Green WR", "volume": "100", "first-page": "1519", "year": "1993", "journal-title": "Ophthalmology", "DOI": "10.1016/S0161-6420(93)31466-1", "doi-asserted-by": "crossref"}, {"key": "sref_5", "author": "Lindblad AS", "volume": "127", "first-page": "1168", "year": "2009", "journal-title": "Arch Ophthalmol", "DOI": "10.1001/archophthalmol.2009.198", "doi-asserted-by": "crossref"}, {"key": "sref_6", "author": "Schmitz-Valckenberg S", "volume": "240", "first-page": "73", "year": "2002", "journal-title": "Graefes Arch Clin Exp Ophthalmol", "DOI": "10.1007/s00417-001-0413-3", "doi-asserted-by": "crossref"}, {"key": "sref_7", "author": "Grisanti S", "volume": "27", "first-page": "372", "year": "2008", "journal-title": "Prog Retin Eye Res", "DOI": "10.1016/j.preteyeres.2008.05.002", "doi-asserted-by": "crossref"}, {"key": "sref_8", "volume": "132", "first-page": "668", "year": "2001", "journal-title": "Am J Ophthalmol", "DOI": "10.1016/S0002-9394(01)01218-1", "doi-asserted-by": "crossref"}, {"key": "sref_9", "author": "Bird AC", "volume": "39", "first-page": "367", "year": "1995", "journal-title": "Surv Ophthalmol", "DOI": "10.1016/S0039-6257(05)80092-X", "doi-asserted-by": "crossref"}, {"key": "sref_10", "author": "Sunness JS", "volume": "114", "first-page": "271", "year": "2007", "journal-title": "Ophthalmology", "DOI": "10.1016/j.ophtha.2006.09.016", "doi-asserted-by": "crossref"}, {"key": "sref_11", "author": "Schatz H", "volume": "96", "first-page": "1541", "year": "1989", "journal-title": "Ophthalmology", "DOI": "10.1016/S0161-6420(89)32694-7", "doi-asserted-by": "crossref"}, {"key": "sref_12", "author": "Sunness JS", "volume": "106", "first-page": "1768", "year": "1999", "journal-title": "Ophthalmology", "DOI": "10.1016/S0161-6420(99)90340-8", "doi-asserted-by": "crossref"}, {"key": "sref_13", "author": "Klein R", "volume": "146", "first-page": "692", "year": "2008", "journal-title": "Am J Ophthalmol", "DOI": "10.1016/j.ajo.2008.05.050", "doi-asserted-by": "crossref"}, {"key": "sref_14", "author": "Sunness JS", "volume": "40", "first-page": "1761", "year": "1999", "journal-title": "Invest Ophthalmol Vis Sci"}, {"key": "sref_15", "author": "Scholl HP", "volume": "241", "first-page": "39", "year": "2003", "journal-title": "Graefes Arch Clin Exp Ophthalmol", "DOI": "10.1007/s00417-002-0602-8", "doi-asserted-by": "crossref"}, {"key": "sref_16", "author": "Pirbhai A", "volume": "139", "first-page": "455", "year": "2005", "journal-title": "Am J Ophthalmol", "DOI": "10.1016/j.ajo.2004.09.077", "doi-asserted-by": "crossref"}, {"key": "sref_17", "author": "Schneider U", "volume": "75", "first-page": "653", "year": "1997", "journal-title": "Acta Ophthalmol Scand", "DOI": "10.1111/j.1600-0420.1997.tb00624.x", "doi-asserted-by": "crossref"}, {"key": "sref_18", "author": "Sparrow JR", "volume": "80", "first-page": "595", "year": "2005", "journal-title": "Exp Eye Res", "DOI": "10.1016/j.exer.2005.01.007", "doi-asserted-by": "crossref"}, {"key": "sref_19", "author": "Boulton M", "volume": "15", "first-page": "384", "year": "2001", "journal-title": "Eye", "DOI": "10.1038/eye.2001.141", "doi-asserted-by": "crossref"}, {"key": "sref_20", "author": "Sch\u00fctt F", "volume": "41", "first-page": "2303", "year": "2000", "journal-title": "Invest Ophthalmol Vis Sci"}, {"key": "sref_21", "author": "Feeney-Burns L", "volume": "25", "first-page": "195", "year": "1984", "journal-title": "Invest Ophthalmol Vis Sci"}, {"key": "sref_22", "author": "Von R\u00fcckmann A", "volume": "79", "first-page": "407", "year": "1995", "journal-title": "Br J Ophthalmol", "DOI": "10.1136/bjo.79.5.407", "doi-asserted-by": "crossref"}, {"key": "sref_23", "author": "Delori FC", "volume": "36", "first-page": "718", "year": "1995", "journal-title": "Invest Ophthalmol Vis Sci"}, {"key": "sref_24", "author": "Bellmann C", "volume": "94", "first-page": "385", "year": "1997", "journal-title": "Ophthalmologe", "DOI": "10.1007/s003470050130", "doi-asserted-by": "crossref"}, {"key": "sref_25", "author": "Von R\u00fcckmann A", "volume": "38", "first-page": "478", "year": "1997", "journal-title": "Invest Ophthalmol Vis Sci"}, {"key": "sref_26", "author": "Solbach U", "volume": "17", "first-page": "385", "year": "1997", "journal-title": "Retina", "DOI": "10.1097/00006982-199709000-00005", "doi-asserted-by": "crossref"}, {"key": "sref_27", "author": "Holz FG", "volume": "143", "first-page": "463", "year": "2007", "journal-title": "Am J Ophthalmol", "DOI": "10.1016/j.ajo.2006.11.041", "doi-asserted-by": "crossref"}, {"key": "sref_28", "author": "Holz FG", "volume": "42", "first-page": "1051", "year": "2001", "journal-title": "Invest Ophthalmol Vis Sci"}, {"key": "sref_29", "author": "Schmitz-Valckenberg S", "volume": "45", "first-page": "4470", "year": "2004", "journal-title": "Invest Ophthalmol Vis Sci", "DOI": "10.1167/iovs.03-1311", "doi-asserted-by": "crossref"}, {"key": "sref_30", "author": "Schmitz-Valckenberg S", "volume": "54", "first-page": "96", "year": "2009", "journal-title": "Surv Ophthalmol", "DOI": "10.1016/j.survophthal.2008.10.004", "doi-asserted-by": "crossref"}, {"key": "sref_31", "author": "Bergmann M", "volume": "18", "first-page": "562", "year": "2004", "journal-title": "FASEB J", "DOI": "10.1096/fj.03-0289fje", "doi-asserted-by": "crossref"}, {"key": "sref_32", "author": "Schutt F", "volume": "44", "first-page": "3663", "year": "2003", "journal-title": "Invest Ophthalmol Vis Sci", "DOI": "10.1167/iovs.03-0172", "doi-asserted-by": "crossref"}, {"key": "sref_33", "author": "Sparrow JR", "volume": "652", "first-page": "315", "year": "2010", "journal-title": "Methods Mol Biol", "DOI": "10.1007/978-1-60327-325-1_18", "doi-asserted-by": "crossref"}, {"key": "sref_34", "author": "Deckert A", "volume": "5", "first-page": "8", "year": "2005", "journal-title": "BMC Ophthalmol", "DOI": "10.1186/1471-2415-5-8", "doi-asserted-by": "crossref"}, {"key": "sref_36", "author": "Bindewald A", "volume": "89", "first-page": "874", "year": "2005", "journal-title": "Br J Ophthalmol", "DOI": "10.1136/bjo.2004.057794", "doi-asserted-by": "crossref"}, {"key": "sref_37", "author": "Scholl HP", "volume": "4", "first-page": "e7418", "year": "2009", "journal-title": "PLoS One", "DOI": "10.1371/journal.pone.0007418", "doi-asserted-by": "crossref"}, {"key": "sref_38", "author": "Schmitz-Valckenberg S", "volume": "47", "first-page": "2648", "year": "2006", "journal-title": "Invest Ophthalmol Vis Sci", "DOI": "10.1167/iovs.05-0892", "doi-asserted-by": "crossref"}, {"key": "sref_39", "author": "Bearelly S", "volume": "31", "first-page": "81", "year": "2011", "journal-title": "Retina", "DOI": "10.1097/IAE.0b013e3181e0958b", "doi-asserted-by": "crossref"}, {"key": "sref_40", "author": "Fleckenstein M", "volume": "51", "first-page": "637", "year": "2010", "journal-title": "Invest Ophthalmol Vis Sci", "DOI": "10.1167/iovs.09-3547", "doi-asserted-by": "crossref"}, {"key": "sref_41", "author": "Csaky KG", "volume": "49", "first-page": "479", "year": "2008", "journal-title": "Invest Ophthalmol Vis Sci", "DOI": "10.1167/iovs.07-1132", "doi-asserted-by": "crossref"}, {"key": "sref_42", "author": "Keilhauer CN", "volume": "47", "first-page": "3556", "year": "2006", "journal-title": "Invest Ophthalmol Vis Sci", "DOI": "10.1167/iovs.06-0122", "doi-asserted-by": "crossref"}, {"key": "sref_43", "author": "Weinberger AW", "volume": "47", "first-page": "3098", "year": "2006", "journal-title": "Invest Ophthalmol Vis Sci", "DOI": "10.1167/iovs.05-1104", "doi-asserted-by": "crossref"}, {"key": "sref_44", "author": "Schmitz-Valckenberg S", "volume": "95", "first-page": "1134", "year": "2011", "journal-title": "Br J Ophthalmol", "DOI": "10.1136/bjo.2010.189498", "doi-asserted-by": "crossref"}, {"key": "sref_45", "author": "Kellner U", "volume": "30", "first-page": "6", "year": "2010", "journal-title": "Retina", "DOI": "10.1097/IAE.0b013e3181b8348b", "doi-asserted-by": "crossref"}, {"key": "sref_46", "author": "Spaide RF", "volume": "110", "first-page": "392", "year": "2003", "journal-title": "Ophthalmology", "DOI": "10.1016/S0161-6420(02)01756-6", "doi-asserted-by": "crossref"}, {"key": "sref_47", "author": "Schmitz-Valckenberg S", "volume": "146", "first-page": "183", "year": "2008", "journal-title": "Am J Ophthalmol", "DOI": "10.1016/j.ajo.2008.04.006", "doi-asserted-by": "crossref"}, {"key": "sref_48", "author": "Bearelly S", "volume": "116", "first-page": "1762", "year": "2009", "journal-title": "Ophthalmology", "DOI": "10.1016/j.ophtha.2009.04.015", "doi-asserted-by": "crossref"}, {"key": "sref_49", "author": "Brar M", "volume": "148", "first-page": "439", "year": "2009", "journal-title": "Am J Ophthalmol", "DOI": "10.1016/j.ajo.2009.04.022", "doi-asserted-by": "crossref"}, {"key": "sref_50", "author": "Fleckenstein M", "volume": "49", "first-page": "4137", "year": "2008", "journal-title": "Invest Ophthalmol Vis Sci", "DOI": "10.1167/iovs.08-1967", "doi-asserted-by": "crossref"}, {"key": "sref_51", "author": "Fleckenstein M", "volume": "51", "first-page": "3846", "year": "2010", "journal-title": "Invest Ophthalmol Vis Sci", "DOI": "10.1167/iovs.09-4533", "doi-asserted-by": "crossref"}, {"key": "sref_52", "author": "Helb HM", "volume": "88", "first-page": "842", "year": "2010", "journal-title": "Acta Ophthalmol", "DOI": "10.1111/j.1755-3768.2009.01602.x", "doi-asserted-by": "crossref"}, {"key": "sref_53", "author": "Lujan BJ", "volume": "40", "first-page": "96", "year": "2009", "journal-title": "Ophthalmic Surg Lasers Imaging", "DOI": "10.3928/15428877-20090301-16", "doi-asserted-by": "crossref"}, {"key": "sref_54", "author": "Schmitz-Valckenberg S", "volume": "50", "first-page": "3915", "year": "2009", "journal-title": "Invest Ophthalmol Vis Sci", "DOI": "10.1167/iovs.08-2484", "doi-asserted-by": "crossref"}, {"key": "sref_55", "author": "Wolf-Schnurrbusch UE", "volume": "49", "first-page": "3095", "year": "2008", "journal-title": "Invest Ophthalmol Vis Sci", "DOI": "10.1167/iovs.07-1460", "doi-asserted-by": "crossref"}, {"key": "sref_56", "author": "Pircher M", "volume": "12", "first-page": "3236", "year": "2004", "journal-title": "Opt Express", "DOI": "10.1364/OPEX.12.003236", "doi-asserted-by": "crossref"}, {"key": "sref_57", "author": "Pircher M", "volume": "47", "first-page": "5487", "year": "2006", "journal-title": "Invest Ophthalmol Vis Sci", "DOI": "10.1167/iovs.05-1589", "doi-asserted-by": "crossref"}, {"key": "sref_58", "author": "Ahlers C", "volume": "51", "first-page": "2149", "year": "2010", "journal-title": "Invest Ophthalmol Vis Sci", "DOI": "10.1167/iovs.09-3817", "doi-asserted-by": "crossref"}, {"key": "sref_60", "author": "Jiao S", "volume": "13", "first-page": "444", "year": "2005", "journal-title": "Opt Express", "DOI": "10.1364/OPEX.13.000444", "doi-asserted-by": "crossref"}, {"key": "sref_61", "author": "Yehoshua Z", "volume": "118", "first-page": "679", "year": "2011", "journal-title": "Ophthalmology", "DOI": "10.1016/j.ophtha.2010.08.018", "doi-asserted-by": "crossref"}, {"key": "sref_62", "author": "Yehoshua Z", "volume": "41", "first-page": "S6", "year": "2010", "journal-title": "Ophthalmic Surg Lasers Imaging", "DOI": "10.3928/15428877-20101031-19", "doi-asserted-by": "crossref"}, {"key": "sref_63", "author": "Fleckenstein M", "volume": "107", "first-page": "1007", "year": "2010", "journal-title": "Ophthalmologe", "DOI": "10.1007/s00347-010-2159-y", "doi-asserted-by": "crossref"}], "container-title": ["Ophthalmologica"], "language": "en", "link": [{"URL": "http://www.karger.com/Article/Pdf/330420", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 18]], "date-time": "2019-06-18T17:12:05Z", "timestamp": 1560877925000}, "score": 40.40472, "issued": {"date-parts": [[2011]]}, "references-count": 61, "journal-issue": {"published-print": {"date-parts": [[2011]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1159/000330420", "relation": {"cites": []}, "ISSN": ["1423-0267", "0030-3755"], "issn-type": [{"value": "0030-3755", "type": "print"}, {"value": "1423-0267", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T09:18:58Z", "timestamp": 1575278338344}, "reference-count": 161, "publisher": "Elsevier", "isbn-type": [{"value": "9780323025980", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2006]]}, "DOI": "10.1016/b978-0-323-02598-0.50066-5", "type": "book-chapter", "created": {"date-parts": [[2013, 9, 19]], "date-time": "2013-09-19T20:44:52Z", "timestamp": 1379623492000}, "page": "1041-1074", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Age-Related Macular Degeneration: Nonneovascular Early AMD, Intermediate AMD, and Geographic Atrophy"], "prefix": "10.1016", "author": [{"given": "Susan B.", "family": "Bressler", "sequence": "first", "affiliation": []}, {"given": "Neil M.", "family": "Bressler", "sequence": "additional", "affiliation": []}, {"given": "Shirley H.", "family": "Sarks", "sequence": "additional", "affiliation": []}, {"given": "John P.", "family": "Sarks", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Retina"], "deposited": {"date-parts": [[2019, 7, 24]], "date-time": "2019-07-24T07:43:26Z", "timestamp": 1563954206000}, "score": 40.40472, "issued": {"date-parts": [[2006]]}, "ISBN": ["9780323025980"], "references-count": 161, "URL": "http://dx.doi.org/10.1016/b978-0-323-02598-0.50066-5"}, {"indexed": {"date-parts": [[2019, 12, 18]], "date-time": "2019-12-18T15:03:24Z", "timestamp": 1576681404995}, "reference-count": 9, "publisher": "Elsevier BV", "issue": "9", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2017, 9, 1]], "date-time": "2017-09-01T00:00:00Z", "timestamp": 1504224000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["clinicalkey.jp", "clinicalkey.com", "aaojournal.org", "clinicalkey.es", "clinicalkey.com.au", "clinicalkey.fr", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Ophthalmology"], "published-print": {"date-parts": [[2017, 9]]}, "DOI": "10.1016/j.ophtha.2017.03.057", "type": "journal-article", "created": {"date-parts": [[2017, 5, 24]], "date-time": "2017-05-24T23:32:17Z", "timestamp": 1495668737000}, "page": "1296-1304", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 38, "title": ["Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial"], "prefix": "10.1016", "volume": "124", "author": [{"given": "Pravin U.", "family": "Dugel", "sequence": "first", "affiliation": []}, {"ORCID": "http://orcid.org/0000-0003-2568-7892", "authenticated-orcid": false, "given": "Glenn J.", "family": "Jaffe", "sequence": "additional", "affiliation": []}, {"given": "Peter", "family": "Sallstig", "sequence": "additional", "affiliation": []}, {"given": "James", "family": "Warburton", "sequence": "additional", "affiliation": []}, {"given": "Andreas", "family": "Weichselberger", "sequence": "additional", "affiliation": []}, {"given": "Mark", "family": "Wieland", "sequence": "additional", "affiliation": []}, {"given": "Lawrence", "family": "Singerman", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Ophthalmology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0161642016324137?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0161642016324137?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 1]], "date-time": "2018-09-01T13:24:07Z", "timestamp": 1535808247000}, "score": 38.746964, "issued": {"date-parts": [[2017, 9]]}, "references-count": 9, "journal-issue": {"published-print": {"date-parts": [[2017, 9]]}, "issue": "9"}, "alternative-id": ["S0161642016324137"], "URL": "http://dx.doi.org/10.1016/j.ophtha.2017.03.057", "ISSN": ["0161-6420"], "issn-type": [{"value": "0161-6420", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial", "name": "articletitle", "label": "Article Title"}, {"value": "Ophthalmology", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.ophtha.2017.03.057", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "\u00a9 2017 by the American Academy of Ophthalmology", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T10:52:03Z", "timestamp": 1574765523231}, "reference-count": 29, "publisher": "SLACK, Inc.", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Ophthalmic Surg Lasers Imaging Retina"], "published-print": {"date-parts": [[2016, 2, 1]]}, "DOI": "10.3928/23258160-20160126-06", "type": "journal-article", "created": {"date-parts": [[2016, 2, 15]], "date-time": "2016-02-15T21:04:18Z", "timestamp": 1455570258000}, "page": "134-141", "source": "Crossref", "is-referenced-by-count": 6, "title": ["Imaging of Melanin Disruption in Age-Related Macular Degeneration Using Multispectral Imaging"], "prefix": "10.3928", "volume": "47", "author": [{"given": "Pravin U.", "family": "Dugel", "sequence": "first", "affiliation": []}, {"given": "Cheryl N.", "family": "Zimmer", "sequence": "additional", "affiliation": []}], "member": "2308", "container-title": ["Ophthalmic Surgery, Lasers and Imaging Retina"], "language": "en", "link": [{"URL": "https://www.healio.com/ophthalmology/journals/osli/2016-2-47-2/%7B067955dc-120c-404d-a54f-69d3e53e51ea%7D/imaging-of-melanin-disruption-in-age-related-macular-degeneration-using-multispectral-imaging", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 29]], "date-time": "2017-06-29T16:33:10Z", "timestamp": 1498753990000}, "score": 37.726624, "issued": {"date-parts": [[2016, 2, 1]]}, "references-count": 29, "journal-issue": {"published-print": {"date-parts": [[2016, 2, 1]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.3928/23258160-20160126-06", "ISSN": ["2325-8160"], "issn-type": [{"value": "2325-8160", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T13:18:32Z", "timestamp": 1575206312727}, "reference-count": 17, "publisher": "IGI Global", "isbn-type": [{"value": "9781522551959", "type": "print"}, {"value": "9781522551966", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2018]]}, "abstract": "<jats:p>Age-related macular degeneration is an eye disease, that gradually degrades the macula, a part of the retina, which is responsible for central vision. It occurs in one of the two types, DRY and WET age-related macular degeneration. In this chapter, to diagnose Age-related macular degeneration, the authors have proposed a new EYENET model which was obtained by combining the modified PNN and modified RBFNN and hence it poses the advantages of both the models. The amount of the disease spread in the retina can be identified by extracting the features of the retina. A total of 250 fundus images were used, out of which 150 were used for training and 100 images were used for testing. Experimental results show that PNN has an accuracy of 87%, modified PNN has an accuracy of 90% RBFNN has an accuracy of 80%, modified RBFNN has an accuracy of 85% and the proposed EYENET Model has an accuracy of 94%. This infers that the proposed EYENET model outperforms all other models.</jats:p>", "DOI": "10.4018/978-1-5225-5195-9.ch010", "type": "book-chapter", "created": {"date-parts": [[2017, 12, 14]], "date-time": "2017-12-14T13:28:54Z", "timestamp": 1513258134000}, "page": "153-171", "source": "Crossref", "is-referenced-by-count": 0, "title": ["A New EYENET Model for Diagnosis of Age-Related Macular Degeneration"], "prefix": "10.4018", "author": [{"given": "Priya", "family": "Kandan", "sequence": "first", "affiliation": [{"name": "Annamalai University, India"}]}, {"given": "P.", "family": "Aruna", "sequence": "additional", "affiliation": [{"name": "Annamalai University, India"}]}], "member": "2432", "reference": [{"key": "978-1-5225-5195-9.ch010.-1", "year": "2010", "article-title": "Retinal Images: Blood Vessel Segmentation by Threshold Probing", "journal-title": "IEEE Symposium On Industrial Electronics And Applications(ISIEA)"}, {"key": "978-1-5225-5195-9.ch010.-2", "DOI": "10.1109/42.974927", "doi-asserted-by": "publisher"}, {"key": "978-1-5225-5195-9.ch010.-3", "unstructured": "Zimmer-Galler, & Zeimer. (2005). Feasibility of Screening for High-Risk Age- Related Macular Degeneration With an Internet-Based Automated Fundus Camera.Ophthalmic Surgery, Lasers & Imaging, 36(3), 228\u2013236.15957480", "DOI": "10.3928/1542-8877-20050501-09", "doi-asserted-by": "crossref"}, {"key": "978-1-5225-5195-9.ch010.-4", "unstructured": "Garc\u00eda, Hornero, Sanchez, Lopez, & D\u00edez. (2007). Feature Extraction and Selection for the Automatic Detection of Hard Exudates in Retinal Images. Proceedings of the 29th Annual International Conference of the IEEE EMBS.", "DOI": "10.1109/IEMBS.2007.4353456", "doi-asserted-by": "crossref"}, {"key": "978-1-5225-5195-9.ch010.-5", "unstructured": "Garcia, Sanchez, Lopez, Abasolo, & Hornero. (2009). Neural network based detection of hard exudates in retinal images. Computer Methods and Programs in Biomedicine, 93, 9-19.", "DOI": "10.1016/j.cmpb.2008.07.006", "doi-asserted-by": "crossref"}, {"key": "978-1-5225-5195-9.ch010.-6", "unstructured": "Garg, Sivaswamy, & Joshi. (2008). Automatic Drusen Detection from Color Retinal Images. Center for Visual Information Technology, IIT Hyderabad."}, {"key": "978-1-5225-5195-9.ch010.-7", "DOI": "10.1109/42.845178", "doi-asserted-by": "publisher"}, {"key": "978-1-5225-5195-9.ch010.-8", "unstructured": "Jayanthi, Devi, & Parvathi. (2010). Automatic Diagnosis of Retinal Diseases from Color Retinal Images. International Journal of Computer Science and Information Security, 7(1), 234-238."}, {"key": "978-1-5225-5195-9.ch010.-9", "DOI": "10.1109/TMI.2006.879955", "doi-asserted-by": "publisher"}, {"key": "978-1-5225-5195-9.ch010.-10", "unstructured": "Nageswara, Uma, Dsvgk, Sridhar, & Rao. (n.d.). A Probabilistic Neural Network Approach For protein Super family Classification. Journal of Theoretical and Applied Information Technology, 6(1), 101 \u2013 105."}, {"issue": "1", "key": "978-1-5225-5195-9.ch010.-11", "first-page": "20", "article-title": "An Automated tracking approach for extraction of retinal vasculature in fndus images.", "volume": "5", "year": "2010", "journal-title": "Journal of Ophthalmic And Vision Research"}, {"key": "978-1-5225-5195-9.ch010.-12", "DOI": "10.1016/j.preteyeres.2005.07.001", "doi-asserted-by": "publisher"}, {"key": "978-1-5225-5195-9.ch010.-13", "unstructured": "Qing. (2004). Segmentation Of Blood Vessels In Retinal Images Using 2-D Entropies Of Gray Level-Gradient Co-Occurrence Matrix. ICASSP, III-509 \u2013 III-512."}, {"key": "978-1-5225-5195-9.ch010.-14", "DOI": "10.1016/S1361-8415(02)00093-2", "doi-asserted-by": "publisher"}, {"key": "978-1-5225-5195-9.ch010.-15", "first-page": "89", "article-title": "Automated Diagnosis of Macular Degeneration through Image Processing. IE(I)", "volume": "3-6", "author": "O.Sheba", "year": "2008", "journal-title": "Journal-CP"}, {"key": "978-1-5225-5195-9.ch010.-16", "first-page": "38", "year": "2009", "article-title": "Classification of Underwater Objects Based on Probabilistic Neural Network", "journal-title": "Fifth International Conference on Natural Computation"}, {"key": "978-1-5225-5195-9.ch010.-17", "unstructured": "Xu & Luo. (2009). Support Vector Machine Based Method For Identifying Hard Exudates In Retinal Images. Academic Press."}], "container-title": ["Ophthalmology"], "link": [{"URL": "https://www.igi-global.com/viewtitle.aspx?TitleId=195767", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 8]], "date-time": "2019-10-08T00:57:21Z", "timestamp": 1570496241000}, "score": 37.50584, "subtitle": ["Diagnosis of Age-Related Macular Degeneration"], "issued": {"date-parts": [[2018]]}, "ISBN": ["9781522551959", "9781522551966"], "references-count": 17, "URL": "http://dx.doi.org/10.4018/978-1-5225-5195-9.ch010", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T03:20:00Z", "timestamp": 1574479200509}, "reference-count": 0, "publisher": "Bentham Science Publishers Ltd.", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CDTH"], "published-print": {"date-parts": [[2012, 5, 1]]}, "DOI": "10.2174/157488512800676039", "type": "journal-article", "created": {"date-parts": [[2012, 5, 31]], "date-time": "2012-05-31T10:44:58Z", "timestamp": 1338461098000}, "page": "90-95", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Age- Related Macular Degeneration"], "prefix": "10.2174", "volume": "7", "author": [{"given": "James", "family": "P. Bolling", "sequence": "first", "affiliation": []}], "member": "965", "container-title": ["Current Drug Therapy"], "language": "en", "link": [{"URL": "http://eurekaselect.com/article/download/98595", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2015, 11, 23]], "date-time": "2015-11-23T14:23:49Z", "timestamp": 1448288629000}, "score": 37.056393, "issued": {"date-parts": [[2012, 5, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2012, 5, 1]]}, "issue": "2"}, "alternative-id": ["LiveAll1"], "URL": "http://dx.doi.org/10.2174/157488512800676039", "ISSN": ["1574-8855"], "issn-type": [{"value": "1574-8855", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T09:06:11Z", "timestamp": 1574413571925}, "reference-count": 71, "publisher": "Elsevier BV", "issue": "11", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2011, 11, 1]], "date-time": "2011-11-01T00:00:00Z", "timestamp": 1320105600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Optometry - Journal of the American Optometric Association"], "published-print": {"date-parts": [[2011, 11]]}, "DOI": "10.1016/j.optm.2011.08.008", "type": "journal-article", "created": {"date-parts": [[2011, 10, 28]], "date-time": "2011-10-28T17:48:31Z", "timestamp": 1319824111000}, "page": "667-680.e6", "source": "Crossref", "is-referenced-by-count": 47, "title": ["Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration"], "prefix": "10.1016", "volume": "82", "author": [{"given": "Stuart P.", "family": "Richer", "sequence": "first", "affiliation": []}, {"given": "William", "family": "Stiles", "sequence": "additional", "affiliation": []}, {"given": "Kelly", "family": "Graham-Hoffman", "sequence": "additional", "affiliation": []}, {"given": "Marc", "family": "Levin", "sequence": "additional", "affiliation": []}, {"given": "Dennis", "family": "Ruskin", "sequence": "additional", "affiliation": []}, {"given": "James", "family": "Wrobel", "sequence": "additional", "affiliation": []}, {"given": "Dong-Wouk", "family": "Park", "sequence": "additional", "affiliation": []}, {"given": "Carla", "family": "Thomas", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Optometry - Journal of the American Optometric Association"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1529183911004489?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1529183911004489?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 18]], "date-time": "2019-06-18T19:38:19Z", "timestamp": 1560886699000}, "score": 36.939236, "issued": {"date-parts": [[2011, 11]]}, "references-count": 71, "journal-issue": {"published-print": {"date-parts": [[2011, 11]]}, "issue": "11"}, "alternative-id": ["S1529183911004489"], "URL": "http://dx.doi.org/10.1016/j.optm.2011.08.008", "ISSN": ["1529-1839"], "issn-type": [{"value": "1529-1839", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T23:21:47Z", "timestamp": 1574464907833}, "reference-count": 36, "publisher": "Elsevier BV", "issue": "7", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2012, 7, 1]], "date-time": "2012-07-01T00:00:00Z", "timestamp": 1341100800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Ophthalmology"], "published-print": {"date-parts": [[2012, 7]]}, "DOI": "10.1016/j.ophtha.2012.01.014", "type": "journal-article", "created": {"date-parts": [[2012, 3, 30]], "date-time": "2012-03-30T13:19:57Z", "timestamp": 1333113597000}, "page": "1425-1431", "source": "Crossref", "is-referenced-by-count": 26, "title": ["Macular Epiretinal Brachytherapy in Treated Age-related Macular Degeneration"], "prefix": "10.1016", "volume": "119", "clinical-trial-number": [{"clinical-trial-number": "nct00809419", "registry": "10.18810/clinical-trials-gov"}], "author": [{"given": "Pravin U.", "family": "Dugel", "sequence": "first", "affiliation": []}, {"given": "Robert", "family": "Petrarca", "sequence": "additional", "affiliation": []}, {"given": "Michael", "family": "Bennett", "sequence": "additional", "affiliation": []}, {"given": "Adiel", "family": "Barak", "sequence": "additional", "affiliation": []}, {"given": "Dov", "family": "Weinberger", "sequence": "additional", "affiliation": []}, {"given": "Jeffrey", "family": "Nau", "sequence": "additional", "affiliation": []}, {"given": "Timothy L.", "family": "Jackson", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Ophthalmology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0161642012000395?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0161642012000395?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 24]], "date-time": "2018-11-24T18:58:46Z", "timestamp": 1543085926000}, "score": 36.34835, "issued": {"date-parts": [[2012, 7]]}, "references-count": 36, "journal-issue": {"published-print": {"date-parts": [[2012, 7]]}, "issue": "7"}, "alternative-id": ["S0161642012000395"], "URL": "http://dx.doi.org/10.1016/j.ophtha.2012.01.014", "ISSN": ["0161-6420"], "issn-type": [{"value": "0161-6420", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}